WO2010141047A1 - Heart valve with anchoring structure having concave landing zone - Google Patents

Heart valve with anchoring structure having concave landing zone Download PDF

Info

Publication number
WO2010141047A1
WO2010141047A1 PCT/US2010/001043 US2010001043W WO2010141047A1 WO 2010141047 A1 WO2010141047 A1 WO 2010141047A1 US 2010001043 W US2010001043 W US 2010001043W WO 2010141047 A1 WO2010141047 A1 WO 2010141047A1
Authority
WO
WIPO (PCT)
Prior art keywords
inflow
heart valve
valve
ring
prosthetic heart
Prior art date
Application number
PCT/US2010/001043
Other languages
French (fr)
Inventor
David R. Elizondo
Andrzej M. Malewicz
Matthew W. Weston
Keith E. Myers
Original Assignee
Ats Medical, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43297999&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2010141047(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ats Medical, Inc. filed Critical Ats Medical, Inc.
Priority to EP21208027.9A priority Critical patent/EP4014927A1/en
Priority to EP10783686.8A priority patent/EP2437688B1/en
Priority to CN201080025834.8A priority patent/CN102481189B/en
Priority to JP2012513922A priority patent/JP2012528670A/en
Priority to EP20172700.5A priority patent/EP3760164B1/en
Priority to ES20172700T priority patent/ES2902446T3/en
Publication of WO2010141047A1 publication Critical patent/WO2010141047A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418Scaffolds therefor, e.g. support stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008Fixation appliances for connecting prostheses to the body
    • A61F2220/0016Fixation appliances for connecting prostheses to the body with sharp anchoring protrusions, e.g. barbs, pins, spikes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004Rounded shapes, e.g. with rounded corners
    • A61F2230/0013Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/0054V-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0065Three-dimensional shapes toroidal, e.g. ring-shaped, doughnut-shaped

Definitions

  • the invention relates to an anchoring structure for use in bioprosthetic heart valve replacement systems. More particularly, the invention relates to a pliant bioprosthetic heart valve supported by a tubular anchoring structure with an inflow end that includes a concave landing zone that reduces paravalvular leakage.
  • valves The transport of vital fluids in the human body is largely regulated by valves.
  • Physiological valves are designed to prevent the backflow of bodily fluids, such as blood, lymph, urine, bile, etc., thereby keeping the body's fluid dynamics unidirectional for proper homeostasis.
  • bodily fluids such as blood, lymph, urine, bile, etc.
  • venous valves maintain the upward flow of blood, particularly from the lower extremities, back toward the heart
  • lymphatic valves prevent the backflow of lymph within the lymph vessels, particularly those of the limbs.
  • valves Because of their common function, valves share certain anatomical features despite variations in relative size.
  • the cardiac valves are among the largest valves in the body with diameters that may exceed 30 mm, while valves of the smaller veins may have diameters no larger than a fraction of a millimeter.
  • valve sinuses can be described as dilations or bulges in the vessel wall that houses the valve.
  • the geometry of the sinus has a function in the operation and fluid dynamics of the valve.
  • One function is to guide fluid flow so as to create eddy currents that prevent the valve leaflets from adhering to the wall of the vessel at the peak of flow velocity, such as during systole.
  • Another function of the sinus geometry is to generate currents that facilitate the precise closing of the leaflets at the beginning of backflow pressure.
  • the sinus geometry is also important in reducing the stress exerted by differential fluid flow pressure on the valve leaflets or cusps as they open and close.
  • the eddy currents occurring within the sinuses of Valsalva in the natural aortic root have been shown to be important in creating smooth, gradual and gentle closure of the aortic valve at the end of systole. Blood is permitted to travel along the curved contour of the sinus and onto the valve leaflets to effect their closure, thereby reducing the pressure that would otherwise be exerted by direct fluid flow onto the valve leaflets.
  • the sinuses of Valsalva also contain the coronary ostia, which are outflow openings of the arteries that feed the heart muscle. When valve sinuses contain such outflow openings, they serve the additional purpose of providing blood flow to such vessels throughout the cardiac cycle.
  • valves When valves exhibit abnormal anatomy and function as a result of valve disease or injury, the unidirectional flow of the physiological fluid they are designed to regulate is disrupted, resulting in increased hydrostatic pressure.
  • venous valvular dysfunction leads to blood flowing back and pooling in the lower legs, resulting in pain, swelling and edema, changes in skin color, and skin ulcerations that can be extremely difficult to treat.
  • Lymphatic valve insufficiency can result in lymphedema with tissue fibrosis and gross distention of the affected body part.
  • Cardiac valvular disease may lead to pulmonary hypertension and edema, atrial fibrillation, and right heart failure in the case of mitral and tricuspid valve stenosis; or pulmonary congestion, left ventricular contractile impairment and congestive heart failure in the case of mitral regurgitation and aortic stenosis.
  • all valvular diseases result in either stenosis, in which the valve does not open properly, impeding fluid flow across it and causing a rise in fluid pressure, or insuff ⁇ ciency/regurgitation, in which the valve does not close properly and the fluid leaks back across the valve, creating backflow.
  • valves are afflicted with both stenosis and insufficiency, in which case the valve neither opens fully nor closes completely.
  • numerous surgical techniques may be used to repair a diseased or damaged heart valve.
  • these surgical techniques may include annuloplasty (contracting the valve annulus), quadrangular resection (narrowing the valve leaflets), commissurotomy (cutting the valve commissures to separate the valve leaflets), or decalcification of valve and annulus tissue.
  • the diseased heart valve may be replaced by a prosthetic valve. Where replacement of a heart valve is indicated, the dysfunctional valve is typically removed and replaced with either a mechanical or tissue valve.
  • Minimally invasive valve replacement procedures have emerged as an alternative to open-chest surgery.
  • a minimally invasive medical procedure is one that is carried out by entering the body through the skin or through a body cavity or anatomical opening, but with the smallest damage possible to these structures.
  • Two types of minimally invasive valve procedures that have emerged are percutaneous valve procedures and trans-apical valve procedures.
  • Percutaneous valve procedures pertain to making small incisions in the skin to allow direct access to peripheral vessels or body channels to insert catheters.
  • Trans-apical valve procedures pertain to making a small incision in or near the apex of a heart to allow valve access. The distinction between percutaneous valve procedures and minimally invasive procedures is also highlighted in a recent position statement, Vassiliades Jr.
  • valves are implanted less and less invasively, the opportunity for suturing the valves around the annulus is reduced.
  • a smaller number of sutures may increase the chance of paravalvular leakage (PVL), i.e. leakage around the valve.
  • PVL paravalvular leakage
  • a smaller number of sutures may also increase the opportunities for migration and valve stability when placed in-vivo.
  • Surgical heart valves include a sewing cuff for direct attachment to the native annulus where the surgeon relies on visual identification to correctly place the inflow ring in the annulus.
  • Minimally invasive heart valves lack any defined feature that interfaces directly with the annulus, instead relying on radial force to hold the valve in position in an attempt to prevent paravalvular leakage.
  • Other conventional designs rely on a "feeler" to locate the native leaflets and when located deploy the valve below the feeler in an attempt to properly seat the valve in the annulus thereby preventing paravalvular leakage.
  • Yet other conventional heart valves rely on a flange construction in which the flange uses double fabric rings to sandwich the device in the native annulus to prevent paravalvular leakage.
  • the double fabric rings require additional surgical time in order for the surgeon to verify that the two rings are placed on opposite sides of the annulus.
  • the invention provides methods and systems for reducing paravalvular leakage around heart valves. As replacement valve procedures become less and less invasive, the opportunity for suturing the valves around the annulus is reduced. However, minimizing the number of sutures used to secure the replacement valve may increase the chance of paravalvular leakage (PVL), as well as the opportunities for valve migration and valve stability when placed in-vivo.
  • PVL paravalvular leakage
  • Leakage associated with a heart valve can be either paravalvular (around the valve) or central (through the valve).
  • Examples of various heart valves include aortic valves, mitral valves, pulmonary valves, and tricuspid valves.
  • Central leakage may be reduced by heart valve design.
  • Paravalvular leakage may be reduced by creating a seal between the replacement heart valve and the implant site to prevent blood from flowing around the replacement heart valve. It is important that the seal between the replacement heart valve and the implant site does not adversely affect the surrounding tissue. Furthermore, it is important that the seal does not affect the flow dynamics around the replacement heart valve. In the case of the aortic valve, it is also important that the seal does not obstruct coronary flow.
  • aortic valve such as a heart valve
  • the current invention is not limited to the aortic valve. While replacement valves are typically implanted in native heart valve positions, the replacement valve systems and sealing devices discussed herein may be used to seal any type of in-vivo valve without departing from the intended scope of the invention.
  • the present heart valve with tubular anchoring structure may be used with minimally invasive procedures such as percutaneous, trans-femoral and trans-apical procedures, it is not limited to such procedures and may also be used with surgical, or so called "open-chest," procedures.
  • a tubular anchoring structure with a concave landing zone includes a body having a proximal or inlet end and a distal or outlet end.
  • the inlet frame has a sinusoidal-shaped single or double rail construction and is commonly referred to as the inlet rim.
  • the outlet frame has a sinusoidal-shaped single or double rail construction.
  • the body of the anchoring structure may be formed of a variety of shapes such as diamond-shaped or hexagonal-shaped patterns.
  • the sinusoidal- shaped single or double rail construction of the inlet rim is C-shaped in cross section and forms the concave landing zone of the invention.
  • a valve assembly that reduces paravalvular leakage.
  • the valve assembly includes a bioprosthetic tissue heart valve attached to an anchoring structure.
  • the anchoring structure includes a body having a proximal or inlet end and a distal or outlet end.
  • the inlet frame has a sinusoidal-shaped single or double rail construction and is commonly referred to as the inlet rim.
  • the outlet frame has a sinusoidal-shaped single, double or triple rail construction and is commonly referred to as the outlet rim.
  • the sinusoidal-shaped construction of the inlet rim is C-shaped in cross section and forms the concave landing zone of the invention.
  • the C-shape in cross section construction provides a bioprosthetic valve that is self-seating and that requires minimal adjustment.
  • a valve prosthesis suitable for implantation in body ducts, the device comprising a main conduit body having an inlet and an outlet and pliant leaflets attached at the outlet so that when a flow passes through the conduit from the inlet to the outlet the leaflets are in an open position allowing the flow to exit the outlet, and when the flow is reversed the leaflets collapse so as to block the outlet, wherein the collapsible leaflets may comprise polyurethane or tissue.
  • the leaflets are attached to the main body at the support beams.
  • the heart valve is movable between a closed position in which the outflow edges of adjacent leaflets engage each other, and an open position in which the outflow edges of adjacent leaflets are separated from each other except along the side edges, the sewn portions of the side edges of the leaflets biasing the leaflets toward a partially closed position.
  • the C-shape in cross section construction forms a landing zone that allows the native annulus to rest in the valley of the inflow region, with the flared rails lying proximally and distally of the annulus.
  • the concave landing zone of the bioprosthetic heart valve assembly provides an effective seal between the bioprosthetic replacement heart valve and the implant site to prevent paravalvular leakage.
  • the inflow rim forming the concave landing zone comprises a single rail construction.
  • the inflow rim forming the concave landing zone comprises a double rail construction.
  • the inflow rim forming the concave landing zone comprises a triple rail construction.
  • the construction of the single, double and/or triple rail may include a proximal portion that is longer than the distal portion, for example, to match the flaring of the aortic valve sinuses.
  • the cross-sectional area of the inflow rim includes direct correspondence of the concave portion of the frame to the native annulus.
  • the frame of the inflow rim engages the native annulus, with the flared inflow rails lying above and below the annulus. The radial force exerted by the self-expanding frame holds the valve in position.
  • a valve prosthesis device suitable for implantation in body ducts, the device comprising a generally cylindrical anchoring structure having deployable construction adapted to be initially crimped in a narrow configuration suitable for surgical, trans-apical, trans-femoral placement, or other catheterization through a body duct, to a target location and adapted to be seated in the target location by the self-expansion of radially compressed forces, the cylindrical anchoring structure provided with a plurality of longitudinally rigid or semi-rigid support beams of fixed length; a valve assembly comprising a flexible conduit having an inlet and an outlet, made of a pliant material having commissural tab portions coupled to the support beams.
  • the invention provides a method of preventing paravalvular leakage.
  • paravalvular leakage may be reduced by ensuring the inflow rim is substantially pushed against the aorta, hence forming a tight seal.
  • a self-expanding replacement valve may be deployed into position with a delivery member, thereby pushing the inflow rim against the aorta to create a seal around the valve.
  • a self-expandable inflow rim comprising the replacement heart valve provides the radial force necessary to position the bioprosthetic heart valve in the annulus.
  • the phrase "generally sinusoidal" is intended to include waves characterized by sine and cosine functions as well as waves which are not rigorously characterized by those functions, but nevertheless resemble such waves.
  • such waves include those which are characterized as having one or more peaks and troughs.
  • a wave whose peaks and troughs are U-shaped or bulbous is intended to be included.
  • waves which are more triangular in shape such as a saw-tooth wave or waves whose peaks and troughs are rectangular.
  • FIG. 1 shows an exemplary valve during normal operation.
  • FIG. IA shows the valve in the open position during peak flow.
  • FIG. IB shows the valve in closed position to prevent backflow of the fluid across the valve.
  • FIG. 2 A is a top view illustrating the anatomy of a typical aortic valve.
  • FIG. 2B is a cross-sectional view of the aortic valve of FIG. 2A.
  • FIG. 2C is a perspective view of the aortic valve of FIG. 2A showing the inflow end, outflow end, and commissural posts in phantom lines
  • FIG. 3 is a schematic representation of the geometry and relative dimensions of the valve sinus region.
  • FIG. 4 is an exemplary bioprosthetic valve for use with the invention.
  • FIG. 5 A is a perspective view of an exemplary embodiment of a tubular anchoring structure in accordance with the invention cut along line A-A and showing a concave landing zone.
  • FIG. 5B is a cross-sectional view of the concave landing zone of FIG. 5A.
  • FIG. 6A is a perspective view of an exemplary embodiment of a anchoring structure in accordance with the invention cut along line A-A and showing a concave landing zone.
  • FIG. 6B is a cross-sectional view of the concave landing zone of FIG. 6A.
  • FIG. 7A is an illustration of a heart showing the bundle of His.
  • FIG. 7B depicts an exemplary embodiment of the tubular anchoring structure of FIG. 5 A including the bioprosthetic heart valve of FIG. 4 showing the concave landing zone positioned within an aorta.
  • FIG. 8 depicts an exemplary embodiment of a tubular anchoring structure including a single rail flared or concave inflow rim dimensioned to lodge inside the sinus cavity.
  • FIG. 9 depicts an alternative perspective view of the single rail flared or concave inflow rim of FIG. 8.
  • FIG. 10 depicts an exemplary heart valve prosthesis with pliant leaflets coupled to a tubular anchoring structure including a concave landing zone covered with optional covering.
  • each of the tubular anchoring structures has an inflow end, referred to herein as an inflow rim, and an outflow end, referred to herein as an outflow rim.
  • inflow and outflow rims “peaks” are concave relative to the proximal end of the anchoring structure and convex relative to the distal end of the anchoring structure.
  • Troughs are convex relative to the proximal end of the anchoring structure and concave relative to the distal end of the anchoring structure.
  • FIGS. IA and IB generally illustrate one exemplary embodiment of a heart valve 1.
  • valve 1 includes a distal outflow end 2, a plurality of leaflets 3, and a proximal inflow end 4.
  • a typical valve functions similar to a collapsible tube in that it opens widely during systole or in response to muscular contraction to enable unobstructed forward flow across the valvular orifice, as illustrated in FIG. IA.
  • the walls of the tube are forced centrally between the sites of attachment to the vessel wall and the valve closes completely as illustrated in FIG. IB.
  • FIGS. 2A, 2B, and 2C illustrate the anatomy of a typical aortic valve.
  • FIG. 2 A shows a top view of a closed valve with three valve sinuses
  • FIG. 2B shows a perspective sectional view of the closed valve
  • FIG. 2C shows a view from outside the vessel wall.
  • Valve sinuses 12 are dilations of the vessel wall that surround the natural valve leaflets. Typically in the aortic valve, each natural valve leaflet has a separate sinus bulge 12 or cavity that allows for maximal opening of the leaflet at peak flow without permitting contact between the leaflet and the vessel wall. As illustrated in FIGS. 2A, 2B, and 2C, the extent of the sinus 12 is generally defined by the commissures 11, vessel wall 13, inflow end 14, and outflow end 15. The proximal intersection between the sinus cavities defines the commissures 1 1. [055] FIGS.
  • valve sinuses form a natural compartment to support the operation of the valve by preventing contact between the leaflets and the vessel wall, which, in turn, may lead to adherence of the leaflets and/or result in detrimental wear and tear of the leaflets.
  • the valve sinuses are also designed to share the stress conditions imposed on the valve leaflets during closure when fluid pressure on the closed leaflets is greatest. The valve sinuses further create favorable fluid dynamics through currents that soften an otherwise abrupt closure of the leaflets under conditions of high backflow pressure. Lastly, the sinuses ensure constant flow to any vessels located within the sinus cavities.
  • FIG. 3 is a schematic representation of the geometry and relative dimensions of the valve sinus region.
  • the valve sinus region is characterized by certain relative dimensions which remain substantially constant regardless of the actual size of the sinuses.
  • the diameter of the sinus is at its largest at the center of the sinus cavities 16, while there is pronounced narrowing of the sinus region at both the inflow annulus 17 near the inflow end 14 and the outflow sinotubular junction 18 near the outflow end 15.
  • the height of the sinus 19 i.e. the distance between inflow annulus 17 and outflow annulus 18
  • the sinus region forms an anatomical compartment with certain constant features that are uniquely adapted to house a valve.
  • the systems and devices of the invention are designed to utilize these anatomical features of the native sinus region for optimal replacement valve function and positioning.
  • FIG. 4 is a perspective view of replacement valve 22, which represents one exemplary embodiment of a typical, tri-leaflet replacement valve useable with the valve replacement system in accordance with the invention.
  • Replacement valve 22 includes valve body 30 having proximal inflow end 31 and a distal outflow end 32.
  • Valve body 30 includes a plurality of valve tissue leaflets 33 joined by seams 34 sewn, stitched or otherwise coupled, wherein each seam 34 is formed by a junction of two leaflets 33.
  • a commissural tab 35 co-extensively formed from the valve material extends from each seam 34 at the distal end of valve body 30.
  • Inflow end 31 of valve body 30 includes a peripheral edge that may be scalloped or straight.
  • inflow end 31 of valve body 30 may optionally comprise reinforcement structure 36 that may be coupled, stitched, adhesively or chemically joined or otherwise attached thereto.
  • the valve replacement system in accordance with the invention may also comprise a reinforcement structure coupled to the bioprosthetic tissue valve and positioned about the inflow end of the tubular anchoring structure as hereinafter will be described.
  • the reinforcement structure may comprise cloth or any porous material that promotes tissue ingrowth. This reinforcement structure may help position and secure the valve prosthesis at the correct position. It may, for example, help hold the valve prosthesis at the inflow annulus when placed in the aortic position.
  • valve replacement systems and devices of the invention are not limited, however, to the specific valve illustrated in FIG. 4.
  • proximal inflow end 31 of valve body 30 is shown in FIG. 4 with a scalloped peripheral edge, other shapes and configurations are contemplated and within the intended scope of the invention.
  • Valve leaflets 33 may be constructed of any . suitable material, including but not limited to expanded polytetrafluoroethylene (ePTFE), equine pericardium, bovine pericardium, or native porcine valve leaflets similar to currently available bioprosthetic aortic valves. Other materials may prove suitable as will be appreciated by one skilled in the art.
  • ePTFE expanded polytetrafluoroethylene
  • bovine pericardium bovine pericardium
  • native porcine valve leaflets similar to currently available bioprosthetic aortic valves.
  • Other materials may prove suitable as will be appreciated by one skilled in the art.
  • FIG. 5 A is a perspective view of an exemplary embodiment of a tubular anchoring structure 24 in accordance with the invention cut along line A-A and laid flat and showing a concave landing zone 60.
  • FIG. 5A represents one exemplary embodiment of a typical anchoring or support structure 24 useable with valve replacement system 20 in accordance with the invention.
  • tubular anchoring structure 24 is designed as a collapsible and expandable anchoring structure adapted to support valve 22 distally along commissural tab region 35 and proximally along the proximal inflow end 31.
  • valve 22 has been detached from tubular anchoring structure 24 so as to focus on the structure and features of the tubular anchoring structure.
  • Anchoring structure 24 has a generally tubular or cylindrical configuration within which replacement valve 22 may be secured, and includes inflow rim 41, support posts 42 and outflow rim 43.
  • Replacement valve 22 may be secured at the proximal inflow end 31 by attachment to inflow rim 41 of tubular anchoring structure 24 and at the distal outflow end 32 via commissural tabs 35 that are threaded through axially extending slots 44, which are formed in support posts 42 that extend longitudinally from inflow rim 41 to outflow rim 43 of tubular anchoring structure 24.
  • distal ends 45 of support posts 42 contact outflow rim 43 of tubular anchoring structure 24, whereas proximal ends 46 of support posts 42 contact inflow rim 41 of tubular anchoring structure 24.
  • Support posts 42 may be rigid, substantially rigid or may also include a degree of inward deflection.
  • a outflow rim 43 of support structure 24 is depicted as comprising a single wire ring or rail that extends between support posts 42 generally at or above the axially extending slots 44 that reside therein.
  • the outflow rim 43 is configured in an undulating or sinusoidal wave pattern forming peaks 47 and troughs 48.
  • the number of rails comprising the outflow rim 43 can comprise numerous other configurations which are contemplated by the invention and may be utilized such as single, double and triple configurations of varying patterns.
  • Inflow rim 41 is depicted as comprising a double wire ring or rail that includes a distal inflow wire ring 49 and a proximal inflow wire ring 51.
  • Distal inflow wire ring 49 and proximal inflow wire ring 51 are configured in an undulating or sinusoidal wave pattern forming peaks 47 and troughs 48.
  • the double wire rail is configured so that a peak 47 of proximal inflow wire ring 51 couples to a trough 48 of distal inflow wire ring 48 thus forming a diamond pattern although any number of desired shapes may be achieved such as pentagonal, hexagonal, rectangular, etc., all of which are within the scope of the invention.
  • the inflow rim 41 optionally includes finger-like elements 53 positioned between distal and proximal inflow wire rings 49, 51 extend in an axial direction therefrom. Finger-like elements 53 are designed to lend additional support to fabric that may cover inflow rim 41 to anchor the fabric and permit tissue ingrowth.
  • outflow rim 43 is formed with a single ring
  • inflow rim 41 is formed with a double ring that extends between support posts 42.
  • the number of rings may vary, and numerous other configurations are contemplated.
  • FIG. 6A illustrates a triple ring construction for the inflow rim
  • FIG. 8 illustrates a single ring construction for the inflow rim.
  • Both inflow rim 41 and outflow rim 43 of tubular anchoring structure 24 may be formed with an undulating or sinusoidal wave-like configurations.
  • inflow rim 41 may have a shorter or longer wavelength (i.e., circumferential dimension from peak to peak) and/or a lesser or greater wave height (i.e., axial dimension from peak to peak) than outflow rim 43.
  • the wavelengths and wave heights of inflow rim 41 and outflow rim 43 may be selected to ensure uniform compression and expansion of tubular anchoring structure 24 without substantial distortion.
  • the wavelength of inflow rim 41 may be further selected to support the geometry of the inflow end of the valve attached thereto, such as the scalloped inflow end 31 of replacement valve 22 shown in FIG. 4. Notably, as shown in FIG.
  • the undulating or sinusoidal wave pattern that forms inflow rim 41 of tubular anchoring structure 24 may be configured such that proximal ends 46 of vertical support posts 42 are connected to troughs 48 of distal inflow ring 49. This arrangement allows the distal inflow wire ring and proximal inflow wire ring to move together when the valve is in its radially compressed state prior to delivery thus preventing possible damage to the bioprosthetic heart valve.
  • the undulating or sinusoidal wave-like pattern that forms outflow rim 43 of support structure 24 may be configured such that distal ends 45 of support posts 42 are connected at a peak 47 of outflow rim 43.
  • Inflow rim 41 comprises a three rail construction including a distal inflow ring 49, a proximal inflow ring 51 and a central inflow ring 62.
  • peaks 47 of proximal inflow ring 51 may be joined to the troughs 64 of central inflow ring 62.
  • Peaks 47 of central inflow ring 62 may be joined to the troughs 48 of distal inflow ring 49.
  • FIG. 5 A and 6A further show that the distal ends 45 of support posts 42 are configured generally in the shape of a paddle with axial slot 44 extending internally within blade 50 of the paddle.
  • Blade 50 of the paddle is oriented toward outflow rim 43 of tubular anchoring structure 24 and connects to outflow rim 43 at a trough of the undulating sinusoidal wave-like pattern of outflow rim 43.
  • An important function of support posts 42 is the stabilization of prosthetic valve 22 in general, and in particular the prevention of any longitudinal extension at points of valve attachment to preclude valve stretching or distortion upon compression of replacement valve system 20.
  • Blades 50 of the paddle-shaped support posts 42 are also designed to accommodate commissural tabs 35 of valve 22.
  • tubular anchoring structure 24 comprises three support posts for a tri-leaflet replacement valve 22 with a sinus that features three natural commissural posts.
  • Support posts 32 of tubular anchoring structure 24 may be structured to generally coincide with the natural commissural posts of the valve sinus.
  • Tubular anchoring structure 24 may be formed from any suitable material including, but not limited to, stainless steel or nitinol. The particular material selected for tubular anchoring structure 24 may be determined based upon whether the support structure is self-expanding or non-self-expanding.
  • preferable materials for self-expanding support structures may include shape memory materials, such as Nitinol.
  • shape memory materials such as Nitinol.
  • the frame of the inflow rim engages the native annulus, with the flared rails 49, 51 lying above and below the annulus. Upon deployment, the radial force exerted by the self-expanding frame holds the valve in position.
  • the concave landing zone 60 of the invention substantially prevents paravalvular leakage. Using the double, triple and single rail flared designs as best seen in FIGS. 5 A, 5 B, 6 A, 6B, 8 and 9 paravalvular leakage may be reduced by ensuring the inflow rim 41, 841 is substantially secured proximally and distally of the annulus, hence forming a tight seal. Concave landing zone 60 also allows the surgeon to easily place the bioprosthetic heart valve in the annulus thus minimizing patient time spent in surgery.
  • FIG. 7 A is an illustration of a heart 700 with right and left atriums 710, 712, right and left ventricles 714, 716, aorta 716 and aortic heart valve 718.
  • the bundle of His 720 also known as the AV bundle or atrioventricular bundle comprises a collection of heart muscle cells specialized for electrical conduction that transmits the electrical impulses from the AV node 722 (located between the atria and the ventricles) to the point of the apex of the fascicular branches.
  • the fascicular branches then lead to the Purkinje fibers which innervate the ventricles, causing the cardiac muscle of the ventricles to contract at a paced interval.
  • each of distal and proximal inflow rims 49, 51 may be substantially of the same vertical height.
  • the proximal ring may be flared slightly less outwardly to avoid compromising or impinging on the bundle of His while the distal ring 49 may be flared slightly more outwardly to ensure solid engagement with the distal side of the aortic annulus.
  • the proximal inflow ring 51 may be constructed to be shorter than the distal inflow ring or may be flared slightly more outwardly so that upon placement, the proximal inflow ring does not contact and does not impinge on the bundle of His.
  • either of the distal or proximal inflow rings 49, 51 may be constructed to be shorter than the other depending on the anatomy of the particular patient and valve replacement involved.
  • both the distal inflow ring 49 and the proximal inflow ring 51 may be comprised of any number of varying vertical heights and degrees of flare without deviating from the spirit of the invention.
  • the heart valve replacement system 20 including the exemplary tubular anchoring structure 24 of FIG. 5A and/or 6A has expanded within the sinus cavities of aorta A, thereby forcing inflow rim 41 against inflow annulus 64 of aorta A to form a tight seal between replacement valve 20 and aorta A. More specifically, upon deployment inflow rim 41 assumes a substantially C- shaped in cross section concave landing zone 60 as can be seen in FIGS. 5B, 6B and 7. Distal inflow ring 49 abuts the distal side of the annulus while proximal inflow ring 51 abuts the proximal side of the native annulus.
  • the concave landing zone 60 prevents and/or minimizes paravalvular leakage and migration of replacement valve 22 from the implantation site.
  • the concave landing zone 60 acts as a gasket to seal the junction between replacement valve system 20 and aorta A.
  • inflow ring 41 is covered with fabric to stimulate tissue ingrowth over time and secure the replacement heart valve in position.
  • the fabric may comprise any suitable material including, but not limited to, woven polyester, polyester velour, polyethylene terepthalate, polytetrafluoroethylene (PTFE), or other biocompatible material.
  • the valve assembly may be compressed in ice, loaded into a delivery system, and deployed into the aortic valve position.
  • the self-expanding characteristic of the anchoring structure provides the radial strength required to hold the valve in position after implant.
  • FIGS. 8 and 9 yet another alternative embodiment of an anchoring structure with a concave landing zone in accordance with the principle of the invention is shown.
  • Valve 822 includes optional reinforcement structure 837.
  • anchoring structure 824 utilizes a diamond and hexagon shaped structure that facilitates collapsibility and dynamic compliance.
  • FIGS. 8 and 9 yet another alternative embodiment of an anchoring structure with a concave landing zone in accordance with the principle of the invention is shown.
  • a valve 822 supported by a generally cylindrical or tubular anchoring structure 824 having a concave landing zone 860 is shown.
  • Valve 822 includes optional reinforcement structure 837.
  • anchoring structure 824 utilizes a diamond and hexagon shaped structure that facilitates collapsibility and dynamic compliance.
  • inflow rim 841 includes a single wire ring that is structured to flare out from the vertical support posts to anchor it firmly against the aortic inflow valve sinus as hereinbefore disclosed.
  • Outflow ring 866 which is depicted as having a two-rail construction, may optionally also be flared-out to anchor it against the aortic outflow annuli of the valve sinuses.
  • the outflow ring 866 of the anchoring structure 824 is adapted to support the commissural tab regions 821 of the valve 822 while the inflow ring 841, depicted as having a single rail construction, allows the anchoring structure 824 to be securely positioned in a sinus cavity of the vascular passageway.
  • Commissural tabs 35 may be stitched directly to the outflow rim or optionally may be stitched to support posts 850.
  • the single ring of the flared inflow ring 841 of the anchoring structure 824 may comprise an undulating or zigzag pattern to which the valve's optional fabric ring or sewing cuff 837 can be sewn.
  • the inflow ring 841 of the anchoring structure may be connected to the outflow ring 866 by vertical support posts 850 that are positioned to coincide with the commissural posts of the native sinus region.
  • the number of vertical support posts may be adapted to the number of native commissural posts present in the particular sinus region.
  • each of the peaks and troughs may be substantially of the same vertical height.
  • either of the peaks or troughs may be constructed to be shorter than the other depending on the anatomy of the particular patient and valve replacement involved.
  • both the single ring construction may be comprised of any number of vertical heights without deviating from the spirit of the invention.
  • Valve 22 is an exemplary embodiment of a typical, tri-leaflet replacement valve useable with the tubular anchoring structure 24 with concave landing zone 60 in accordance with the invention.
  • the replacement valve may also be of two leaflet construction.
  • Replacement valve 22 includes valve body 30 having proximal inflow end 31 and a distal outflow end 32.
  • Valve body 30 includes a plurality of valve tissue leaflets 33.
  • a commissural tab 35 co-extensively formed from the valve material extends from each seam 34 at the distal end of valve body 30. As shown in FIG.
  • valve body 30 optionally includes reinforcement structure 36 that may be coupled, stitched, adhesively or chemically joined or otherwise attached thereto.
  • the valve replacement system 20 in accordance may also comprise a reinforcement structure coupled to the bioprosthetic tissue valve and positioned about the inflow end of the tubular anchoring structure.
  • the reinforcement structure may comprise cloth or any porous material that promotes tissue in- growth. This reinforcement structure may help position and secure the valve prosthesis at the correct position. It may, for example, help hold the valve " prosthesis at the inflow annulus when placed in the aortic position.
  • Single outflow rail 43 of tubular anchoring structure 24 is operably coupled to paddle-shaped blade 50.
  • commissural tabs 35 of the valve 22 are aligned with axially extending slots 44 formed in support posts 42.
  • the overall size of the slots 44 correspond in size with tabs 35.
  • tabs 35 may be optionally covered with a cloth covering 37.
  • valve leaflets 33 may be constructed of any suitable material, including but not limited to expanded polytetrafluoroethylene (ePTFE), equine pericardium, bovine pericardium, or native porcine valve leaflets similar to currently available bioprosthetic aortic valves. Other materials may prove suitable as will be appreciated by one skilled in the art.
  • ePTFE expanded polytetrafluoroethylene
  • bovine pericardium bovine pericardium
  • native porcine valve leaflets similar to currently available bioprosthetic aortic valves.
  • Other materials may prove suitable as will be appreciated by one skilled in the art.
  • novel anchoring structure device and bioprosthetic valve system in accordance with the invention is designed to be fitted in the annulus without sutures of any kind.
  • sutures may or may not be used to secure the bioprosthetic valve system in place in the annulus.
  • the anchoring structure is cut from a smaller tube and expanded and heat set to the final desired size.
  • the tips of the single inflow ring and the tips distal inflow ring and the proximal inflow ring in the double and triple constructions may be flared outwardly to form the C-shaped in cross section concave region extending from the cylindrical body of the anchoring structure frame. Additional fingers, such as those shown in FIG. 5 A, may be used in any of the constructions and may be flared outwardly to assist in engaging the annulus and support the fabric covering.

Abstract

A device for reducing paravalvular leakage upon implantation of a replacement heart valve is provided. The valve assembly includes a tissue or bioprosthetic heart valve attached to an anchoring structure. The anchoring structure includes an inlet rim that is substantially C-shaped in cross section to form a concave landing zone. The anchoring structure self-seats when implanted in the sinus of a patient with the proximal and distal ends of the C-shaped inlet rim pushed against the proximal and distal portions of the aortic annulus to effectively prevent paravalvular leakage.

Description

HEART VALVE WITH ANCHORING STRUCTURE HAVING CONCAVE
LANDING ZONE
BACKGROUND OF THE INVENTION
FIELD OF THE INVENTION
[001] The invention relates to an anchoring structure for use in bioprosthetic heart valve replacement systems. More particularly, the invention relates to a pliant bioprosthetic heart valve supported by a tubular anchoring structure with an inflow end that includes a concave landing zone that reduces paravalvular leakage.
DESCRIPTION OF THE RELATED ART
[002] The transport of vital fluids in the human body is largely regulated by valves. Physiological valves are designed to prevent the backflow of bodily fluids, such as blood, lymph, urine, bile, etc., thereby keeping the body's fluid dynamics unidirectional for proper homeostasis. For example, venous valves maintain the upward flow of blood, particularly from the lower extremities, back toward the heart, while lymphatic valves prevent the backflow of lymph within the lymph vessels, particularly those of the limbs.
[003] Because of their common function, valves share certain anatomical features despite variations in relative size. The cardiac valves are among the largest valves in the body with diameters that may exceed 30 mm, while valves of the smaller veins may have diameters no larger than a fraction of a millimeter.
Regardless of their size, however, many physiological valves are situated in specialized anatomical structures known as sinuses. Valve sinuses can be described as dilations or bulges in the vessel wall that houses the valve. The geometry of the sinus has a function in the operation and fluid dynamics of the valve. One function is to guide fluid flow so as to create eddy currents that prevent the valve leaflets from adhering to the wall of the vessel at the peak of flow velocity, such as during systole. Another function of the sinus geometry is to generate currents that facilitate the precise closing of the leaflets at the beginning of backflow pressure. The sinus geometry is also important in reducing the stress exerted by differential fluid flow pressure on the valve leaflets or cusps as they open and close.
[004] Thus, for example, the eddy currents occurring within the sinuses of Valsalva in the natural aortic root have been shown to be important in creating smooth, gradual and gentle closure of the aortic valve at the end of systole. Blood is permitted to travel along the curved contour of the sinus and onto the valve leaflets to effect their closure, thereby reducing the pressure that would otherwise be exerted by direct fluid flow onto the valve leaflets. The sinuses of Valsalva also contain the coronary ostia, which are outflow openings of the arteries that feed the heart muscle. When valve sinuses contain such outflow openings, they serve the additional purpose of providing blood flow to such vessels throughout the cardiac cycle.
[005] When valves exhibit abnormal anatomy and function as a result of valve disease or injury, the unidirectional flow of the physiological fluid they are designed to regulate is disrupted, resulting in increased hydrostatic pressure. For example, venous valvular dysfunction leads to blood flowing back and pooling in the lower legs, resulting in pain, swelling and edema, changes in skin color, and skin ulcerations that can be extremely difficult to treat. Lymphatic valve insufficiency can result in lymphedema with tissue fibrosis and gross distention of the affected body part. Cardiac valvular disease may lead to pulmonary hypertension and edema, atrial fibrillation, and right heart failure in the case of mitral and tricuspid valve stenosis; or pulmonary congestion, left ventricular contractile impairment and congestive heart failure in the case of mitral regurgitation and aortic stenosis. Regardless of their etiology, all valvular diseases result in either stenosis, in which the valve does not open properly, impeding fluid flow across it and causing a rise in fluid pressure, or insuffϊciency/regurgitation, in which the valve does not close properly and the fluid leaks back across the valve, creating backflow. Some valves are afflicted with both stenosis and insufficiency, in which case the valve neither opens fully nor closes completely. [006] Because of the potential severity of the clinical consequences of valve disease, numerous surgical techniques may be used to repair a diseased or damaged heart valve. For example, these surgical techniques may include annuloplasty (contracting the valve annulus), quadrangular resection (narrowing the valve leaflets), commissurotomy (cutting the valve commissures to separate the valve leaflets), or decalcification of valve and annulus tissue. Alternatively, the diseased heart valve may be replaced by a prosthetic valve. Where replacement of a heart valve is indicated, the dysfunctional valve is typically removed and replaced with either a mechanical or tissue valve. [007] In the past, one common procedure has been an open-heart type procedure. However, open-heart valve repair or replacement surgery is a long and tedious procedure and involves a gross thoracotomy, usually in the form of a median sternotomy. In this procedure, a saw or other cutting instrument is used to cut the sternum longitudinally and the two opposing halves of the anterior or ventral portion of the rib cage are spread apart. A large opening into the thoracic cavity is thus created, through which the surgeon may directly visualize and operate upon the heart and other thoracic contents. Replacement heart valves typically include a sewing ring and are sutured into the annulus, resulting in a time intensive surgical procedure. The patient is typically placed on cardiopulmonary bypass for the duration of the surgery.
[008] Minimally invasive valve replacement procedures have emerged as an alternative to open-chest surgery. A minimally invasive medical procedure is one that is carried out by entering the body through the skin or through a body cavity or anatomical opening, but with the smallest damage possible to these structures. Two types of minimally invasive valve procedures that have emerged are percutaneous valve procedures and trans-apical valve procedures. Percutaneous valve procedures pertain to making small incisions in the skin to allow direct access to peripheral vessels or body channels to insert catheters. Trans-apical valve procedures pertain to making a small incision in or near the apex of a heart to allow valve access. The distinction between percutaneous valve procedures and minimally invasive procedures is also highlighted in a recent position statement, Vassiliades Jr. TA, Block PC, Cohn LH, Adams DH, Borer JS, Feldman T, Holmes DR, Laskey WK, Lytle BW, Mack MF, Williams DO. The clinical development of percutaneous heart valve technology: a position statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society for Cardiovascular Angiography and Interventions (SCAI). J Thorac Cardiovasc Surg 2005; 129:970-6).
[009] As valves are implanted less and less invasively, the opportunity for suturing the valves around the annulus is reduced. However, a smaller number of sutures may increase the chance of paravalvular leakage (PVL), i.e. leakage around the valve. A smaller number of sutures may also increase the opportunities for migration and valve stability when placed in-vivo.
[010] Tehrani discloses a superior and inferior o-ring for valve implantation in US Patent Application Publication No. 2006/0271172. Such o-rings cover the entire length of the valve and can therefore not easily be placed within the aortic sinus region. The o-rings presented by Tehrani would also block coronary outflow and adversely affect valve dynamics. The non-circular nature of the o- rings also reduces the radial force needed to adequately conform to irregularities within the implantation site, and is thus not optimal for preventing PVL and migration. The large size of the o-rings disclosed by Tehrani is also not practical as they cannot easily be collapsed down, something that is necessary for minimally invasive valve implantation.
[011] Surgical heart valves include a sewing cuff for direct attachment to the native annulus where the surgeon relies on visual identification to correctly place the inflow ring in the annulus. Minimally invasive heart valves, however, lack any defined feature that interfaces directly with the annulus, instead relying on radial force to hold the valve in position in an attempt to prevent paravalvular leakage. Other conventional designs rely on a "feeler" to locate the native leaflets and when located deploy the valve below the feeler in an attempt to properly seat the valve in the annulus thereby preventing paravalvular leakage. Yet other conventional heart valves rely on a flange construction in which the flange uses double fabric rings to sandwich the device in the native annulus to prevent paravalvular leakage. However, the double fabric rings require additional surgical time in order for the surgeon to verify that the two rings are placed on opposite sides of the annulus.
[012] In addition, while new less invasive valves produce beneficial results for many patients, these valves may not work as well for other patients who have calcified or irregular annuluses because a tight seal may not be formed between the replacement valve and the implantation site. Therefore, what is needed are methods, systems, and devices for reducing paravalvular leakage around heart valves while preventing valve migration and allowing valve collapsibility. [013] The invention is directed to solving, or at least reducing, some or all of the aforementioned problems.
BRIEF SUMMARY OF THE INVENTION
[014] The invention provides methods and systems for reducing paravalvular leakage around heart valves. As replacement valve procedures become less and less invasive, the opportunity for suturing the valves around the annulus is reduced. However, minimizing the number of sutures used to secure the replacement valve may increase the chance of paravalvular leakage (PVL), as well as the opportunities for valve migration and valve stability when placed in-vivo.
[015] Leakage associated with a heart valve can be either paravalvular (around the valve) or central (through the valve). Examples of various heart valves include aortic valves, mitral valves, pulmonary valves, and tricuspid valves. Central leakage may be reduced by heart valve design. Paravalvular leakage, on the other hand, may be reduced by creating a seal between the replacement heart valve and the implant site to prevent blood from flowing around the replacement heart valve. It is important that the seal between the replacement heart valve and the implant site does not adversely affect the surrounding tissue. Furthermore, it is important that the seal does not affect the flow dynamics around the replacement heart valve. In the case of the aortic valve, it is also important that the seal does not obstruct coronary flow. [016] Accordingly, it is one object of the invention to provide methods and devices for preventing paravalvular leakage around a replacement valve, such as a heart valve, while also preventing migration. It should be noted that while reference is made herein to aortic valves, the current invention is not limited to the aortic valve. While replacement valves are typically implanted in native heart valve positions, the replacement valve systems and sealing devices discussed herein may be used to seal any type of in-vivo valve without departing from the intended scope of the invention. Moreover, while the present heart valve with tubular anchoring structure may be used with minimally invasive procedures such as percutaneous, trans-femoral and trans-apical procedures, it is not limited to such procedures and may also be used with surgical, or so called "open-chest," procedures.
[017] In one embodiment of the invention a tubular anchoring structure with a concave landing zone is provided. The anchoring structure includes a body having a proximal or inlet end and a distal or outlet end. The inlet frame has a sinusoidal-shaped single or double rail construction and is commonly referred to as the inlet rim. The outlet frame has a sinusoidal-shaped single or double rail construction. The body of the anchoring structure may be formed of a variety of shapes such as diamond-shaped or hexagonal-shaped patterns. The sinusoidal- shaped single or double rail construction of the inlet rim is C-shaped in cross section and forms the concave landing zone of the invention.
[018] In another embodiment of the invention, a valve assembly that reduces paravalvular leakage is provided. The valve assembly includes a bioprosthetic tissue heart valve attached to an anchoring structure. The anchoring structure includes a body having a proximal or inlet end and a distal or outlet end. The inlet frame has a sinusoidal-shaped single or double rail construction and is commonly referred to as the inlet rim. The outlet frame has a sinusoidal-shaped single, double or triple rail construction and is commonly referred to as the outlet rim. The sinusoidal-shaped construction of the inlet rim is C-shaped in cross section and forms the concave landing zone of the invention. The C-shape in cross section construction provides a bioprosthetic valve that is self-seating and that requires minimal adjustment.
[019] In another embodiment of the invention, there is provided a valve prosthesis suitable for implantation in body ducts, the device comprising a main conduit body having an inlet and an outlet and pliant leaflets attached at the outlet so that when a flow passes through the conduit from the inlet to the outlet the leaflets are in an open position allowing the flow to exit the outlet, and when the flow is reversed the leaflets collapse so as to block the outlet, wherein the collapsible leaflets may comprise polyurethane or tissue. [020] In yet another embodiment of the present invention, the leaflets are attached to the main body at the support beams.
[021] In yet another embodiment of the invention the heart valve is movable between a closed position in which the outflow edges of adjacent leaflets engage each other, and an open position in which the outflow edges of adjacent leaflets are separated from each other except along the side edges, the sewn portions of the side edges of the leaflets biasing the leaflets toward a partially closed position.
[022] In another embodiment of the invention, the C-shape in cross section construction forms a landing zone that allows the native annulus to rest in the valley of the inflow region, with the flared rails lying proximally and distally of the annulus.
[023] In yet another embodiment of the invention, the concave landing zone of the bioprosthetic heart valve assembly provides an effective seal between the bioprosthetic replacement heart valve and the implant site to prevent paravalvular leakage. [024] In yet another embodiment of the invention, the inflow rim forming the concave landing zone comprises a single rail construction.
[025] In yet another embodiment of the invention, the inflow rim forming the concave landing zone comprises a double rail construction. [026] In a further embodiment of the invention, the inflow rim forming the concave landing zone comprises a triple rail construction.
[027] In a further embodiment of the invention, the construction of the single, double and/or triple rail may include a proximal portion that is longer than the distal portion, for example, to match the flaring of the aortic valve sinuses.
[028] In another embodiment of the invention, the cross-sectional area of the inflow rim includes direct correspondence of the concave portion of the frame to the native annulus. The frame of the inflow rim engages the native annulus, with the flared inflow rails lying above and below the annulus. The radial force exerted by the self-expanding frame holds the valve in position.
[029] In yet another embodiment of the present invention, there is provided a valve prosthesis device suitable for implantation in body ducts, the device comprising a generally cylindrical anchoring structure having deployable construction adapted to be initially crimped in a narrow configuration suitable for surgical, trans-apical, trans-femoral placement, or other catheterization through a body duct, to a target location and adapted to be seated in the target location by the self-expansion of radially compressed forces, the cylindrical anchoring structure provided with a plurality of longitudinally rigid or semi-rigid support beams of fixed length; a valve assembly comprising a flexible conduit having an inlet and an outlet, made of a pliant material having commissural tab portions coupled to the support beams.
[030] The invention provides a method of preventing paravalvular leakage. Using the single, double and/or triple rail flared designs described herein, paravalvular leakage may be reduced by ensuring the inflow rim is substantially pushed against the aorta, hence forming a tight seal. In one method of implantation, a self-expanding replacement valve may be deployed into position with a delivery member, thereby pushing the inflow rim against the aorta to create a seal around the valve. In other words, a self-expandable inflow rim comprising the replacement heart valve provides the radial force necessary to position the bioprosthetic heart valve in the annulus. [031] It should be noted that for the purposes of this invention, the phrase "generally sinusoidal" is intended to include waves characterized by sine and cosine functions as well as waves which are not rigorously characterized by those functions, but nevertheless resemble such waves. In a more general way, such waves include those which are characterized as having one or more peaks and troughs. As an example, a wave whose peaks and troughs are U-shaped or bulbous is intended to be included. Also intended to be included, without limiting the definition, are waves which are more triangular in shape such as a saw-tooth wave or waves whose peaks and troughs are rectangular. [032] Although many of the above embodiments are described in reference to the aortic valve in the heart, the claimed invention may also be utilized for procedures related to other valves including, but not limited to, the mitral valve, tricuspid valve, and the pulmonary valve.
[033] The above aspects, features and advantages of the invention will become apparent to those skilled in the art from the following description taken together with the accompanying figures.
BRIEF DESCRIPTION OF THE DRAWINGS
[034] FIG. 1 shows an exemplary valve during normal operation. FIG. IA shows the valve in the open position during peak flow. [035] FIG. IB shows the valve in closed position to prevent backflow of the fluid across the valve.
[036] FIG. 2 A is a top view illustrating the anatomy of a typical aortic valve. [037] FIG. 2B is a cross-sectional view of the aortic valve of FIG. 2A.
[038] FIG. 2C is a perspective view of the aortic valve of FIG. 2A showing the inflow end, outflow end, and commissural posts in phantom lines
[039] FIG. 3 is a schematic representation of the geometry and relative dimensions of the valve sinus region.
[040] FIG. 4 is an exemplary bioprosthetic valve for use with the invention. [041] FIG. 5 A is a perspective view of an exemplary embodiment of a tubular anchoring structure in accordance with the invention cut along line A-A and showing a concave landing zone.
[042] FIG. 5B is a cross-sectional view of the concave landing zone of FIG. 5A.
[043] FIG. 6A is a perspective view of an exemplary embodiment of a anchoring structure in accordance with the invention cut along line A-A and showing a concave landing zone.
[044] FIG. 6B is a cross-sectional view of the concave landing zone of FIG. 6A.
[045] FIG. 7A is an illustration of a heart showing the bundle of His.
[046] FIG. 7B depicts an exemplary embodiment of the tubular anchoring structure of FIG. 5 A including the bioprosthetic heart valve of FIG. 4 showing the concave landing zone positioned within an aorta. [047] FIG. 8 depicts an exemplary embodiment of a tubular anchoring structure including a single rail flared or concave inflow rim dimensioned to lodge inside the sinus cavity.
[048] FIG. 9 depicts an alternative perspective view of the single rail flared or concave inflow rim of FIG. 8. [049] FIG. 10 depicts an exemplary heart valve prosthesis with pliant leaflets coupled to a tubular anchoring structure including a concave landing zone covered with optional covering.
DETAILED DESCRIPTION OF THE INVENTION
[050] While this invention may be embodied in many different forms, there are described in detail herein various embodiments of the invention. This description is an exemplification of the principles of the invention and is not intended to limit the invention to the particular embodiments illustrated.
[051] For the sake of consistency, the terms "peak" and "trough" are defined with respect to the proximal and distal ends of the anchoring structure in accordance with the invention. As seen in the Figures, each of the tubular anchoring structures has an inflow end, referred to herein as an inflow rim, and an outflow end, referred to herein as an outflow rim. With respect to the inflow and outflow rims "peaks" are concave relative to the proximal end of the anchoring structure and convex relative to the distal end of the anchoring structure. Troughs, on the other hand, are convex relative to the proximal end of the anchoring structure and concave relative to the distal end of the anchoring structure.
[052] Turning now to the FIGS., the invention relates to methods, systems, and devices for reducing paravalvular leakage in heart valves. FIGS. IA and IB generally illustrate one exemplary embodiment of a heart valve 1. As illustrated in FIG. 1, valve 1 includes a distal outflow end 2, a plurality of leaflets 3, and a proximal inflow end 4. A typical valve functions similar to a collapsible tube in that it opens widely during systole or in response to muscular contraction to enable unobstructed forward flow across the valvular orifice, as illustrated in FIG. IA. In contrast, as forward flow decelerates at the end of systole or contraction, the walls of the tube are forced centrally between the sites of attachment to the vessel wall and the valve closes completely as illustrated in FIG. IB.
[053] FIGS. 2A, 2B, and 2C illustrate the anatomy of a typical aortic valve. In particular, FIG. 2 A shows a top view of a closed valve with three valve sinuses, FIG. 2B shows a perspective sectional view of the closed valve, and FIG. 2C shows a view from outside the vessel wall.
[054] One important consideration in the design of valve replacement systems and devices is the architecture of the valve sinus. Valve sinuses 12 are dilations of the vessel wall that surround the natural valve leaflets. Typically in the aortic valve, each natural valve leaflet has a separate sinus bulge 12 or cavity that allows for maximal opening of the leaflet at peak flow without permitting contact between the leaflet and the vessel wall. As illustrated in FIGS. 2A, 2B, and 2C, the extent of the sinus 12 is generally defined by the commissures 11, vessel wall 13, inflow end 14, and outflow end 15. The proximal intersection between the sinus cavities defines the commissures 1 1. [055] FIGS. 2B and 2C also show the narrowing diameter of the sinuses at both inflow end 14 and outflow end 15, thus forming the annulus and sinotubular junction, respectively, of the sinus region. Thus, the valve sinuses form a natural compartment to support the operation of the valve by preventing contact between the leaflets and the vessel wall, which, in turn, may lead to adherence of the leaflets and/or result in detrimental wear and tear of the leaflets. The valve sinuses are also designed to share the stress conditions imposed on the valve leaflets during closure when fluid pressure on the closed leaflets is greatest. The valve sinuses further create favorable fluid dynamics through currents that soften an otherwise abrupt closure of the leaflets under conditions of high backflow pressure. Lastly, the sinuses ensure constant flow to any vessels located within the sinus cavities.
[056] FIG. 3 is a schematic representation of the geometry and relative dimensions of the valve sinus region. As shown in FIG. 3, the valve sinus region is characterized by certain relative dimensions which remain substantially constant regardless of the actual size of the sinuses. Generally, the diameter of the sinus is at its largest at the center of the sinus cavities 16, while there is pronounced narrowing of the sinus region at both the inflow annulus 17 near the inflow end 14 and the outflow sinotubular junction 18 near the outflow end 15. Furthermore, the height of the sinus 19 (i.e. the distance between inflow annulus 17 and outflow annulus 18) remains substantially proportional to its overall dimensions. It is thus apparent that the sinus region forms an anatomical compartment with certain constant features that are uniquely adapted to house a valve. The systems and devices of the invention are designed to utilize these anatomical features of the native sinus region for optimal replacement valve function and positioning.
[057] FIG. 4 is a perspective view of replacement valve 22, which represents one exemplary embodiment of a typical, tri-leaflet replacement valve useable with the valve replacement system in accordance with the invention. One of ordinary skill in the art will appreciate that the replacement valve may also be of two leaflet construction. Replacement valve 22 includes valve body 30 having proximal inflow end 31 and a distal outflow end 32. Valve body 30 includes a plurality of valve tissue leaflets 33 joined by seams 34 sewn, stitched or otherwise coupled, wherein each seam 34 is formed by a junction of two leaflets 33. A commissural tab 35 co-extensively formed from the valve material extends from each seam 34 at the distal end of valve body 30. Inflow end 31 of valve body 30 includes a peripheral edge that may be scalloped or straight. In addition, inflow end 31 of valve body 30 may optionally comprise reinforcement structure 36 that may be coupled, stitched, adhesively or chemically joined or otherwise attached thereto. The valve replacement system in accordance with the invention may also comprise a reinforcement structure coupled to the bioprosthetic tissue valve and positioned about the inflow end of the tubular anchoring structure as hereinafter will be described. The reinforcement structure may comprise cloth or any porous material that promotes tissue ingrowth. This reinforcement structure may help position and secure the valve prosthesis at the correct position. It may, for example, help hold the valve prosthesis at the inflow annulus when placed in the aortic position.
[058] The valve replacement systems and devices of the invention are not limited, however, to the specific valve illustrated in FIG. 4. For example, although the proximal inflow end 31 of valve body 30 is shown in FIG. 4 with a scalloped peripheral edge, other shapes and configurations are contemplated and within the intended scope of the invention. Valve leaflets 33 may be constructed of any . suitable material, including but not limited to expanded polytetrafluoroethylene (ePTFE), equine pericardium, bovine pericardium, or native porcine valve leaflets similar to currently available bioprosthetic aortic valves. Other materials may prove suitable as will be appreciated by one skilled in the art.
[059] FIG. 5 A is a perspective view of an exemplary embodiment of a tubular anchoring structure 24 in accordance with the invention cut along line A-A and laid flat and showing a concave landing zone 60. FIG. 5A represents one exemplary embodiment of a typical anchoring or support structure 24 useable with valve replacement system 20 in accordance with the invention. In general, tubular anchoring structure 24 is designed as a collapsible and expandable anchoring structure adapted to support valve 22 distally along commissural tab region 35 and proximally along the proximal inflow end 31. As shown in FIG. 5 A, valve 22 has been detached from tubular anchoring structure 24 so as to focus on the structure and features of the tubular anchoring structure.
[060] Anchoring structure 24 has a generally tubular or cylindrical configuration within which replacement valve 22 may be secured, and includes inflow rim 41, support posts 42 and outflow rim 43. Replacement valve 22 may be secured at the proximal inflow end 31 by attachment to inflow rim 41 of tubular anchoring structure 24 and at the distal outflow end 32 via commissural tabs 35 that are threaded through axially extending slots 44, which are formed in support posts 42 that extend longitudinally from inflow rim 41 to outflow rim 43 of tubular anchoring structure 24. Thus, distal ends 45 of support posts 42 contact outflow rim 43 of tubular anchoring structure 24, whereas proximal ends 46 of support posts 42 contact inflow rim 41 of tubular anchoring structure 24. Support posts 42 may be rigid, substantially rigid or may also include a degree of inward deflection.
[061] As shown in FIG. 5 A outflow rim 43 of support structure 24 is depicted as comprising a single wire ring or rail that extends between support posts 42 generally at or above the axially extending slots 44 that reside therein. The outflow rim 43 is configured in an undulating or sinusoidal wave pattern forming peaks 47 and troughs 48. However, the number of rails comprising the outflow rim 43 can comprise numerous other configurations which are contemplated by the invention and may be utilized such as single, double and triple configurations of varying patterns. Inflow rim 41 is depicted as comprising a double wire ring or rail that includes a distal inflow wire ring 49 and a proximal inflow wire ring 51.
Distal inflow wire ring 49 and proximal inflow wire ring 51 are configured in an undulating or sinusoidal wave pattern forming peaks 47 and troughs 48. As can be seen, the double wire rail is configured so that a peak 47 of proximal inflow wire ring 51 couples to a trough 48 of distal inflow wire ring 48 thus forming a diamond pattern although any number of desired shapes may be achieved such as pentagonal, hexagonal, rectangular, etc., all of which are within the scope of the invention.
[062] The inflow rim 41 optionally includes finger-like elements 53 positioned between distal and proximal inflow wire rings 49, 51 extend in an axial direction therefrom. Finger-like elements 53 are designed to lend additional support to fabric that may cover inflow rim 41 to anchor the fabric and permit tissue ingrowth.
[063] In an exemplary embodiment of a tubular anchoring structure 24 illustrated in FIG. 5 A, outflow rim 43 is formed with a single ring, while inflow rim 41 is formed with a double ring that extends between support posts 42. However, the number of rings may vary, and numerous other configurations are contemplated. For example, FIG. 6A illustrates a triple ring construction for the inflow rim while FIG. 8 illustrates a single ring construction for the inflow rim. [064] Both inflow rim 41 and outflow rim 43 of tubular anchoring structure 24 may be formed with an undulating or sinusoidal wave-like configurations. In various embodiments of tubular anchoring structures, inflow rim 41 may have a shorter or longer wavelength (i.e., circumferential dimension from peak to peak) and/or a lesser or greater wave height (i.e., axial dimension from peak to peak) than outflow rim 43. The wavelengths and wave heights of inflow rim 41 and outflow rim 43 may be selected to ensure uniform compression and expansion of tubular anchoring structure 24 without substantial distortion. The wavelength of inflow rim 41 may be further selected to support the geometry of the inflow end of the valve attached thereto, such as the scalloped inflow end 31 of replacement valve 22 shown in FIG. 4. Notably, as shown in FIG. 5A, the undulating or sinusoidal wave pattern that forms inflow rim 41 of tubular anchoring structure 24 may be configured such that proximal ends 46 of vertical support posts 42 are connected to troughs 48 of distal inflow ring 49. This arrangement allows the distal inflow wire ring and proximal inflow wire ring to move together when the valve is in its radially compressed state prior to delivery thus preventing possible damage to the bioprosthetic heart valve. Similarly, the undulating or sinusoidal wave-like pattern that forms outflow rim 43 of support structure 24 may be configured such that distal ends 45 of support posts 42 are connected at a peak 47 of outflow rim 43.
[065] As shown in FIG. 6 A, an alternative embodiment of an inflow rim 41 is shown. Inflow rim 41 comprises a three rail construction including a distal inflow ring 49, a proximal inflow ring 51 and a central inflow ring 62. In this alternative three-rail construction for inflow rim 41, peaks 47 of proximal inflow ring 51 may be joined to the troughs 64 of central inflow ring 62. Peaks 47 of central inflow ring 62 may be joined to the troughs 48 of distal inflow ring 49. This arrangement allows the distal inflow wire ring and proximal inflow wire ring to move together when the valve is in its radially compressed state prior to delivery thus preventing possible damage to the bioprosthetic heart valve.
[066] FIG. 5 A and 6A further show that the distal ends 45 of support posts 42 are configured generally in the shape of a paddle with axial slot 44 extending internally within blade 50 of the paddle. Blade 50 of the paddle is oriented toward outflow rim 43 of tubular anchoring structure 24 and connects to outflow rim 43 at a trough of the undulating sinusoidal wave-like pattern of outflow rim 43. An important function of support posts 42 is the stabilization of prosthetic valve 22 in general, and in particular the prevention of any longitudinal extension at points of valve attachment to preclude valve stretching or distortion upon compression of replacement valve system 20. Blades 50 of the paddle-shaped support posts 42 are also designed to accommodate commissural tabs 35 of valve 22.
[067] The number of support posts 42 generally ranges from two to four, depending on the number of commissural posts present in the valve sinus. Thus, in one embodiment of the invention, tubular anchoring structure 24 comprises three support posts for a tri-leaflet replacement valve 22 with a sinus that features three natural commissural posts. Support posts 32 of tubular anchoring structure 24 may be structured to generally coincide with the natural commissural posts of the valve sinus. [068] Tubular anchoring structure 24 may be formed from any suitable material including, but not limited to, stainless steel or nitinol. The particular material selected for tubular anchoring structure 24 may be determined based upon whether the support structure is self-expanding or non-self-expanding. For example, preferable materials for self-expanding support structures may include shape memory materials, such as Nitinol. [069] Turning now to FIGS. 5 B and 6B a cross-sectional view of the inflow rim 41 is depicted which illustrates the concave landing zone 60 in accordance with the invention. As can be seen, peaks 47 of the distal inflow ring 49 and troughs 48 of the proximal inflow ring 51 flare outwardly so that inflow rim 41 forms a C-shape in cross section upon deployment. This cross-sectional area 60 of the inflow rim 41, or in other words the concave portion of the frame, directly corresponds to the native annulus. The frame of the inflow rim engages the native annulus, with the flared rails 49, 51 lying above and below the annulus. Upon deployment, the radial force exerted by the self-expanding frame holds the valve in position. [070] The concave landing zone 60 of the invention substantially prevents paravalvular leakage. Using the double, triple and single rail flared designs as best seen in FIGS. 5 A, 5 B, 6 A, 6B, 8 and 9 paravalvular leakage may be reduced by ensuring the inflow rim 41, 841 is substantially secured proximally and distally of the annulus, hence forming a tight seal. Concave landing zone 60 also allows the surgeon to easily place the bioprosthetic heart valve in the annulus thus minimizing patient time spent in surgery.
[071] FIG. 7 A is an illustration of a heart 700 with right and left atriums 710, 712, right and left ventricles 714, 716, aorta 716 and aortic heart valve 718. The bundle of His 720, also known as the AV bundle or atrioventricular bundle comprises a collection of heart muscle cells specialized for electrical conduction that transmits the electrical impulses from the AV node 722 (located between the atria and the ventricles) to the point of the apex of the fascicular branches. The fascicular branches then lead to the Purkinje fibers which innervate the ventricles, causing the cardiac muscle of the ventricles to contract at a paced interval. If the bundle of His is blocked, a serious condition called "third degree heart block," namely the dissociation between the activity of the atria and that of the ventricles, occurs. A third degree block most likely requires an artificial pacemaker. Consequently, a great number of heart valve replacement surgeries result in secondary operations to implant a pacemaker because the stented portion of the heart valve impinges on the bundle of His. [072] Thus, those of ordinary skill in the art will appreciate that there are many different configurations that may be employed for the distal and proximal inflow rings 49, 51. For example, each of distal and proximal inflow rims 49, 51 may be substantially of the same vertical height. If each of distal and proximal inflow rings 49, 51 are substantially the same vertical height, the proximal ring may be flared slightly less outwardly to avoid compromising or impinging on the bundle of His while the distal ring 49 may be flared slightly more outwardly to ensure solid engagement with the distal side of the aortic annulus. Alternatively, the proximal inflow ring 51 may be constructed to be shorter than the distal inflow ring or may be flared slightly more outwardly so that upon placement, the proximal inflow ring does not contact and does not impinge on the bundle of His. Alternatively, either of the distal or proximal inflow rings 49, 51 may be constructed to be shorter than the other depending on the anatomy of the particular patient and valve replacement involved. Those of ordinary skill in the art will appreciate, however, that both the distal inflow ring 49 and the proximal inflow ring 51 may be comprised of any number of varying vertical heights and degrees of flare without deviating from the spirit of the invention.
[073] As shown in FIG. 7B, the heart valve replacement system 20 including the exemplary tubular anchoring structure 24 of FIG. 5A and/or 6A has expanded within the sinus cavities of aorta A, thereby forcing inflow rim 41 against inflow annulus 64 of aorta A to form a tight seal between replacement valve 20 and aorta A. More specifically, upon deployment inflow rim 41 assumes a substantially C- shaped in cross section concave landing zone 60 as can be seen in FIGS. 5B, 6B and 7. Distal inflow ring 49 abuts the distal side of the annulus while proximal inflow ring 51 abuts the proximal side of the native annulus. [074] The concave landing zone 60 prevents and/or minimizes paravalvular leakage and migration of replacement valve 22 from the implantation site. Thus, with inflow ring 41 in contact with inflow annulus 64, the concave landing zone 60 acts as a gasket to seal the junction between replacement valve system 20 and aorta A. Optionally, inflow ring 41 is covered with fabric to stimulate tissue ingrowth over time and secure the replacement heart valve in position. The fabric may comprise any suitable material including, but not limited to, woven polyester, polyester velour, polyethylene terepthalate, polytetrafluoroethylene (PTFE), or other biocompatible material. The valve assembly may be compressed in ice, loaded into a delivery system, and deployed into the aortic valve position. The self-expanding characteristic of the anchoring structure provides the radial strength required to hold the valve in position after implant.
[075] Turning now to FIGS. 8 and 9, yet another alternative embodiment of an anchoring structure with a concave landing zone in accordance with the principle of the invention is shown. A valve 822 supported by a generally cylindrical or tubular anchoring structure 824 having a concave landing zone 860 is shown. Valve 822 includes optional reinforcement structure 837. In this embodiment, anchoring structure 824 utilizes a diamond and hexagon shaped structure that facilitates collapsibility and dynamic compliance. Those skilled in the art however will appreciate that there are numerous designs for the anchoring structure that can be utilized. As can be seen from FIGS. 8 and 9, inflow rim 841 includes a single wire ring that is structured to flare out from the vertical support posts to anchor it firmly against the aortic inflow valve sinus as hereinbefore disclosed. Outflow ring 866, which is depicted as having a two-rail construction, may optionally also be flared-out to anchor it against the aortic outflow annuli of the valve sinuses. The outflow ring 866 of the anchoring structure 824 is adapted to support the commissural tab regions 821 of the valve 822 while the inflow ring 841, depicted as having a single rail construction, allows the anchoring structure 824 to be securely positioned in a sinus cavity of the vascular passageway. Commissural tabs 35 may be stitched directly to the outflow rim or optionally may be stitched to support posts 850. The single ring of the flared inflow ring 841 of the anchoring structure 824 may comprise an undulating or zigzag pattern to which the valve's optional fabric ring or sewing cuff 837 can be sewn. The inflow ring 841 of the anchoring structure may be connected to the outflow ring 866 by vertical support posts 850 that are positioned to coincide with the commissural posts of the native sinus region. However, it should be understood that the number of vertical support posts may be adapted to the number of native commissural posts present in the particular sinus region. [076] Those of ordinary skill in the art will appreciate that there are many different configurations that can be employed for the configuration of inflow rim 841 or outflow rim 866. For example, each of the peaks and troughs may be substantially of the same vertical height. Alternatively, either of the peaks or troughs may be constructed to be shorter than the other depending on the anatomy of the particular patient and valve replacement involved. Those of ordinary skill in the art will appreciate, however, that both the single ring construction may be comprised of any number of vertical heights without deviating from the spirit of the invention.
[077] Referring to FlG. 10 a perspective view of prosthetic heart valve 22 is shown mounted in a tubular anchoring structure with concave landing zone (not shown). Valve 22 is an exemplary embodiment of a typical, tri-leaflet replacement valve useable with the tubular anchoring structure 24 with concave landing zone 60 in accordance with the invention. One of ordinary skill in the art will appreciate that the replacement valve may also be of two leaflet construction. Replacement valve 22 includes valve body 30 having proximal inflow end 31 and a distal outflow end 32. Valve body 30 includes a plurality of valve tissue leaflets 33. A commissural tab 35 co-extensively formed from the valve material extends from each seam 34 at the distal end of valve body 30. As shown in FIG. 10 inflow end 31 of valve body 30 optionally includes reinforcement structure 36 that may be coupled, stitched, adhesively or chemically joined or otherwise attached thereto. The valve replacement system 20 in accordance may also comprise a reinforcement structure coupled to the bioprosthetic tissue valve and positioned about the inflow end of the tubular anchoring structure. The reinforcement structure may comprise cloth or any porous material that promotes tissue in- growth. This reinforcement structure may help position and secure the valve prosthesis at the correct position. It may, for example, help hold the valve " prosthesis at the inflow annulus when placed in the aortic position. Single outflow rail 43 of tubular anchoring structure 24 is operably coupled to paddle-shaped blade 50. In use, the commissural tabs 35 of the valve 22 are aligned with axially extending slots 44 formed in support posts 42. The overall size of the slots 44 correspond in size with tabs 35. In addition, tabs 35 may be optionally covered with a cloth covering 37.
[078] As noted above, valve leaflets 33 may be constructed of any suitable material, including but not limited to expanded polytetrafluoroethylene (ePTFE), equine pericardium, bovine pericardium, or native porcine valve leaflets similar to currently available bioprosthetic aortic valves. Other materials may prove suitable as will be appreciated by one skilled in the art.
[079] It should be noted that the novel anchoring structure device and bioprosthetic valve system in accordance with the invention is designed to be fitted in the annulus without sutures of any kind. However, those of ordinary skill in the art will also appreciate that sutures may or may not be used to secure the bioprosthetic valve system in place in the annulus.
[080] During manufacture, the anchoring structure is cut from a smaller tube and expanded and heat set to the final desired size. Depending on the design, the tips of the single inflow ring and the tips distal inflow ring and the proximal inflow ring in the double and triple constructions may be flared outwardly to form the C-shaped in cross section concave region extending from the cylindrical body of the anchoring structure frame. Additional fingers, such as those shown in FIG. 5 A, may be used in any of the constructions and may be flared outwardly to assist in engaging the annulus and support the fabric covering. [081] Although the invention has been described with reference to preferred embodiments, workers skilled in the art will recognize that changes may be made in form and detail without departing from the spirit and scope of the invention.

Claims

WHAT IS CLAIMED IS:
1. A prosthetic heart valve configured to be positioned within an aortic annulus comprising: a generally cylindrical anchoring structure having an inflow end, an outlet end, and a plurality of support posts therebetween; an inflow rim formed with said tubular body at the inflow end, said inflow rim including at least one rail having outwardly flared distal and proximal portions that form a substantially C-shaped in cross section concave landing zone; a pliant prosthetic heart valve including a plurality of leaflets coupled together along at least a portion of their side edges so as to form a substantially tubular valve structure having an inflow end and an outflow end, said outflow end including a plurality of commissure tabs integrally formed with said leaflets, said commissure tabs coupled to said support posts, wherein the heart valve is movable between a closed position in which the outflow edges of adjacent leaflets engage each other, and an open position in which the outflow edges of adjacent leaflets are separated from each other except along the side edges, the sewn portions of the side edges of the leaflets biasing the leaflets toward a partially closed position.
2. The prosthetic heart valve of claim 1 wherein said inflow rim comprises a single rail.
3. The prosthetic heart valve of claim 1 wherein said inflow rim comprises a double rail including a distal inflow ring and a proximal inflow ring.
4. The prosthetic heart valve of claim 3 wherein said distal inflow ring and said proximal inflow ring are configured in a sinusoidal wave pattern forming a plurality of peaks and a plurality of troughs.
5. The prosthetic heart valve of claim 4 wherein at least one of said plurality of peaks of said proximal inflow ring is operably connected with a trough of at least one of said plurality of troughs of said distal inflow ring.
6. The prosthetic heart valve of claim 1 further comprising a plurality of finger elements extending axially from said inflow rim.
7. The prosthetic heart valve of claim 3 further comprising a plurality of finger elements extending axially from said proximal inflow ring and said distal inflow ring.
8. The prosthetic heart valve of claim 1 further comprising an outflow rim having at least one rail, said outflow rim operably connected with said tubular body.
9. The prosthetic heart valve of claim 8 wherein said outflow rim includes flared distal and proximal portions that form a substantially C-shaped in cross section concave landing zone.
10. The prosthetic heart valve of claim 1 wherein said inflow rim comprises a triple rail including a distal inflow ring operably connected to a central inflow ring and a proximal inflow ring operably connected to said central inflow ring.
11. The prosthetic heart valve of claim 10 wherein said distal inflow ring, said central inflow ring and said proximal inflow ring are configured in a sinusoidal wave pattern forming a plurality of peaks and a plurality of troughs.
12. The prosthetic heart valve of claim 11 wherein said peaks of said distal inflow ring and operably connected to the troughs of said central inflow ring and said peaks of central inflow ring are operably connected to the troughs of said proximal inflow ring.
13. The prosthetic heart valve of claim 1 further comprising a plurality of longitudinal supports posts connecting said inflow and outflow rims.
14. The prosthetic heart valve of claim 13 wherein said support posts include a substantially paddle-shaped blade having an axial slot therethrough and an elongated vertical member.
15. The prosthetic heart valve of claim 14 wherein said elongated vertical member is coupled to said inflow rim and said blade is coupled to said outflow rim.
16. The prosthetic heart valve of claim 15 further comprising a bioprosthetic heat valve including at least two commissural tabs operably coupled with said blade.
17. The prosthetic heart valve of claim 13 wherein said plurality of longitudinal support posts comprise two support posts.
18. The prosthetic heart valve of claim 13 wherein said plurality of longitudinal support posts comprise three support posts.
19. The prosthetic heart valve of claim 1 wherein said distal portion of said C- shaped in cross section concave landing zone is configured to lie proximate the distal side of the aortic annulus and the proximal portion of said C-shaped in cross section concave landing zone is configured to lie proximate the proximal side of the aortic annulus.
20. The prosthetic heart valve of claim 19 wherein the proximal portion of said C-Shaped in cross section concave landing zone is configured to avoid contact with the bundle of His.
21. The prosthetic heart valve of claim 1 wherein said C-shaped in cross section concave landing zone is configured to form a seal between the prosthetic heart valve and the aortic annulus.
22. The prosthetic heart valve of claim 21 wherein said seal substantially reduces or prevents paravalvular leakage.
23. The prosthetic heart valve of claim 21 wherein said seal substantially prevents migration of said heart valve from the implantation site.
24. An anchoring structure adapted to be anchored within a vessel of a body, said anchoring structure comprising a generally cylindrical tubular body having an inflow end and an outflow end; and an inflow rim co- extensively formed with said tubular body at the inflow end, said inflow rim including at least one rail having outwardly flared distal and proximal portions.
25. The prosthetic heart valve of claim 24 wherein said inflow rim comprises a single rail.
26. The prosthetic heart valve of claim 24 wherein said inflow rim comprises a double rail including a distal inflow ring and a proximal inflow ring.
27. The anchoring structure of claim 26 wherein said distal inflow ring and said proximal inflow ring are configured in a sinusoidal wave pattern forming a plurality of peaks and a plurality of troughs.
28. The anchoring structure of claim 27 wherein at least one of said plurality of peaks of said proximal inflow ring is operably connected with a trough of at least one of said plurality of troughs of said distal inflow ring.
29. The anchoring structure of claim 24 further comprising a plurality of finger elements extending axially from said inflow rim.
30. The anchoring structure of claim 26 further comprising a plurality of finger elements extending axially from said proximal inflow ring and said distal inflow ring.
31. The anchoring structure of claim 24 further comprising an outflow rim having at least one rail, said outflow rim operably connected with said tubular body.
32. The anchoring structure of claim 31 wherein said outflow rim includes flared distal and proximal portions that form a substantially C-shaped in cross section concave landing zone.
33. The anchoring structure of claim 24 wherein said inflow rim comprises a triple rail including a distal inflow ring operably connected to a central inflow ring and a proximal inflow ring operably connected to said central inflow ring.
34. The anchoring structure of claim 33 wherein said distal inflow ring, said central inflow ring and said proximal inflow ring are configured in a sinusoidal wave pattern forming a plurality of peaks and a plurality of troughs.
35. The anchoring structure of claim 34 wherein said peaks of said distal inflow ring and operably connected to the troughs of said central inflow ring and said peaks of central inflow ring are operably connected to the troughs of said proximal inflow ring.
36. The anchoring structure of claim 24 further comprising a plurality of longitudinal supports posts connecting said inflow and outflow rims.
37. The anchoring structure of claim 36 wherein said support posts include a substantially paddle-shaped blade having an axial slot therethrough and an elongated vertical member.
38. The anchoring structure of claim 37 wherein said elongated vertical member is coupled to said inflow rim and said blade is coupled to said outflow rim.
39. The anchoring structure of claim 38 further comprising a bioprosthetic heat valve including at least two commissural tabs operably coupled with said blade.
40. The anchoring structure of claim 36 wherein said plurality of longitudinal support posts comprise two support posts.
41. The anchoring structure of claim 36 wherein said plurality of longitudinal support posts comprise three support posts.
PCT/US2010/001043 2009-06-05 2010-04-07 Heart valve with anchoring structure having concave landing zone WO2010141047A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP21208027.9A EP4014927A1 (en) 2009-06-05 2010-04-07 Heart valve with anchoring structure having concave landing zone
EP10783686.8A EP2437688B1 (en) 2009-06-05 2010-04-07 Heart valve with anchoring structure having concave landing zone
CN201080025834.8A CN102481189B (en) 2009-06-05 2010-04-07 Anchoring structure with concave landing zone
JP2012513922A JP2012528670A (en) 2009-06-05 2010-04-07 Heart valve with anchoring structure having a concave ground area
EP20172700.5A EP3760164B1 (en) 2009-06-05 2010-04-07 Heart valve with anchoring structure having concave landing zone
ES20172700T ES2902446T3 (en) 2009-06-05 2010-04-07 Heart valve with anchoring structure that has a concave resting area

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US18465009P 2009-06-05 2009-06-05
US61/184,650 2009-06-05
US12/603,315 2009-10-21
US12/603,315 US9579194B2 (en) 2003-10-06 2009-10-21 Anchoring structure with concave landing zone

Publications (1)

Publication Number Publication Date
WO2010141047A1 true WO2010141047A1 (en) 2010-12-09

Family

ID=43297999

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/001043 WO2010141047A1 (en) 2009-06-05 2010-04-07 Heart valve with anchoring structure having concave landing zone

Country Status (7)

Country Link
US (1) US9579194B2 (en)
EP (3) EP3760164B1 (en)
JP (1) JP2012528670A (en)
CN (1) CN102481189B (en)
ES (1) ES2902446T3 (en)
PT (1) PT3760164T (en)
WO (1) WO2010141047A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102014102718A1 (en) * 2014-02-28 2015-09-03 Highlife Sas Transcatheter valve prosthesis
US9375312B2 (en) 2010-07-09 2016-06-28 Highlife Sas Transcatheter atrio-ventricular valve prosthesis
US9763779B2 (en) 2014-03-11 2017-09-19 Highlife Sas Transcatheter valve prosthesis

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008260444B2 (en) * 2007-06-04 2014-09-11 St. Jude Medical, Inc. Prosthetic heart valves
ES2571740T3 (en) 2007-09-26 2016-05-26 St Jude Medical Collapsible prosthetic heart valves
US9532868B2 (en) 2007-09-28 2017-01-03 St. Jude Medical, Inc. Collapsible-expandable prosthetic heart valves with structures for clamping native tissue
US8157853B2 (en) * 2008-01-24 2012-04-17 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
ES2570592T3 (en) 2008-07-15 2016-05-19 St Jude Medical Collapsible and re-expandable prosthetic heart valve sleeve designs and complementary technological applications
AU2009295960A1 (en) * 2008-09-29 2010-04-01 Cardiaq Valve Technologies, Inc. Heart valve
US8795354B2 (en) 2010-03-05 2014-08-05 Edwards Lifesciences Corporation Low-profile heart valve and delivery system
US8579964B2 (en) 2010-05-05 2013-11-12 Neovasc Inc. Transcatheter mitral valve prosthesis
PL3498225T3 (en) 2010-10-05 2020-11-16 Edwards Lifesciences Corporation Prosthetic heart valve
US9155619B2 (en) 2011-02-25 2015-10-13 Edwards Lifesciences Corporation Prosthetic heart valve delivery apparatus
US9308087B2 (en) 2011-04-28 2016-04-12 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US9474598B2 (en) 2011-10-05 2016-10-25 Boston Scientific Scimed, Inc. Profile reduction seal
US9427315B2 (en) 2012-04-19 2016-08-30 Caisson Interventional, LLC Valve replacement systems and methods
US9011515B2 (en) 2012-04-19 2015-04-21 Caisson Interventional, LLC Heart valve assembly systems and methods
US9345573B2 (en) 2012-05-30 2016-05-24 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
US9675451B2 (en) * 2013-02-01 2017-06-13 Medtronic CV Luxembourg S.a.r.l. Anti-paravalvular leakage component for a transcatheter valve prosthesis
US10918479B2 (en) 2013-02-25 2021-02-16 Shanghai Microport Cardioflow Medtech Co., Ltd. Heart valve prosthesis
CN104000672B (en) * 2013-02-25 2016-06-15 上海微创心通医疗科技有限公司 Heart valve prosthesis
US9572665B2 (en) 2013-04-04 2017-02-21 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
JP2016517748A (en) * 2013-05-03 2016-06-20 メドトロニック,インコーポレイテッド Medical device and related methods for implantation in a valve
JP6561044B2 (en) 2013-05-03 2019-08-14 メドトロニック,インコーポレイテッド Valve transfer tool
US9375311B2 (en) 2013-05-03 2016-06-28 Medtronic, Inc. Prosthetic valves and associated appartuses, systems and methods
US9050188B2 (en) 2013-10-23 2015-06-09 Caisson Interventional, LLC Methods and systems for heart valve therapy
US9913715B2 (en) 2013-11-06 2018-03-13 St. Jude Medical, Cardiology Division, Inc. Paravalvular leak sealing mechanism
US9974647B2 (en) 2014-06-12 2018-05-22 Caisson Interventional, LLC Two stage anchor and mitral valve assembly
US9750605B2 (en) 2014-10-23 2017-09-05 Caisson Interventional, LLC Systems and methods for heart valve therapy
US9750607B2 (en) 2014-10-23 2017-09-05 Caisson Interventional, LLC Systems and methods for heart valve therapy
US10080652B2 (en) * 2015-03-13 2018-09-25 Boston Scientific Scimed, Inc. Prosthetic heart valve having an improved tubular seal
US10327892B2 (en) 2015-08-11 2019-06-25 Boston Scientific Scimed Inc. Integrated adaptive seal for prosthetic heart valves
US10368983B2 (en) * 2015-08-12 2019-08-06 St. Jude Medical, Cardiology Division, Inc. Collapsible heart valve including stents with tapered struts
EP3397208B1 (en) 2015-12-30 2020-12-02 Caisson Interventional, LLC Systems for heart valve therapy
EP3407835A4 (en) 2016-01-29 2019-06-26 Neovasc Tiara Inc. Prosthetic valve for avoiding obstruction of outflow
CA3042588A1 (en) 2016-11-21 2018-05-24 Neovasc Tiara Inc. Methods and systems for rapid retraction of a transcatheter heart valve delivery system
US10561495B2 (en) 2017-01-24 2020-02-18 4C Medical Technologies, Inc. Systems, methods and devices for two-step delivery and implantation of prosthetic heart valve
US10856984B2 (en) 2017-08-25 2020-12-08 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
EP3459469A1 (en) 2017-09-23 2019-03-27 Universität Zürich Medical occluder device
US11439732B2 (en) 2018-02-26 2022-09-13 Boston Scientific Scimed, Inc. Embedded radiopaque marker in adaptive seal
US11857441B2 (en) 2018-09-04 2024-01-02 4C Medical Technologies, Inc. Stent loading device
WO2020093172A1 (en) 2018-11-08 2020-05-14 Neovasc Tiara Inc. Ventricular deployment of a transcatheter mitral valve prosthesis
CN113507902A (en) * 2019-01-17 2021-10-15 爱德华兹生命科学公司 Frame for prosthetic heart valve
CA3135753C (en) 2019-04-01 2023-10-24 Neovasc Tiara Inc. Controllably deployable prosthetic valve
AU2020271896B2 (en) 2019-04-10 2022-10-13 Neovasc Tiara Inc. Prosthetic valve with natural blood flow
US11439504B2 (en) 2019-05-10 2022-09-13 Boston Scientific Scimed, Inc. Replacement heart valve with improved cusp washout and reduced loading
CN114025813A (en) 2019-05-20 2022-02-08 内奥瓦斯克迪亚拉公司 Introducer with hemostatic mechanism
US11311376B2 (en) 2019-06-20 2022-04-26 Neovase Tiara Inc. Low profile prosthetic mitral valve
EP4033999A2 (en) 2019-09-26 2022-08-03 Universität Zürich Left atrial appendage occlusion devices
US11931253B2 (en) 2020-01-31 2024-03-19 4C Medical Technologies, Inc. Prosthetic heart valve delivery system: ball-slide attachment
US20210275298A1 (en) * 2020-03-04 2021-09-09 Medtronic, Inc. Balloon expandable stent with lengthened commissure posts for transcatheter implantation of a cardiac valve prosthesis

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070270944A1 (en) * 2004-04-23 2007-11-22 3F Therapeutics, Inc. Implantable Valve Prosthesis
US20080071362A1 (en) * 2006-09-19 2008-03-20 Yosi Tuval Valve prosthesis implantation techniques
US20080281411A1 (en) * 2004-03-26 2008-11-13 Eric Berreklouw Assembly Comprising A Ring For Attachment In A Passage Surrounded By Body Tissue As Well As An Applicator For Fitting The Ring In The Passage
US20090005863A1 (en) * 2006-02-16 2009-01-01 Goetz Wolfgang Minimally invasive heart valve replacement

Family Cites Families (499)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3587115A (en) 1966-05-04 1971-06-28 Donald P Shiley Prosthetic sutureless heart valves and implant tools therefor
US3540431A (en) 1968-04-04 1970-11-17 Kazi Mobin Uddin Collapsible filter for fluid flowing in closed passageway
US3671979A (en) 1969-09-23 1972-06-27 Univ Utah Catheter mounted artificial heart valve for implanting in close proximity to a defective natural heart valve
US3628535A (en) 1969-11-12 1971-12-21 Nibot Corp Surgical instrument for implanting a prosthetic heart valve or the like
US3642004A (en) * 1970-01-05 1972-02-15 Life Support Equipment Corp Urethral valve
US3657744A (en) 1970-05-08 1972-04-25 Univ Minnesota Method for fixing prosthetic implants in a living body
US3714671A (en) * 1970-11-30 1973-02-06 Cutter Lab Tissue-type heart valve with a graft support ring or stent
US3868956A (en) * 1972-06-05 1975-03-04 Ralph J Alfidi Vessel implantable appliance and method of implanting it
US3839741A (en) 1972-11-17 1974-10-08 J Haller Heart valve and retaining means therefor
US3795246A (en) * 1973-01-26 1974-03-05 Bard Inc C R Venocclusion device
US3874388A (en) 1973-02-12 1975-04-01 Ochsner Med Found Alton Shunt defect closure system
US4291420A (en) 1973-11-09 1981-09-29 Medac Gesellschaft Fur Klinische Spezialpraparate Mbh Artificial heart valve
US4035849A (en) 1975-11-17 1977-07-19 William W. Angell Heart valve stent and process for preparing a stented heart valve prosthesis
US4056854A (en) 1976-09-28 1977-11-08 The United States Of America As Represented By The Department Of Health, Education And Welfare Aortic heart valve catheter
US4297749A (en) 1977-04-25 1981-11-03 Albany International Corp. Heart valve prosthesis
US4233690A (en) 1978-05-19 1980-11-18 Carbomedics, Inc. Prosthetic device couplings
US4265694A (en) 1978-12-14 1981-05-05 The United States Of America As Represented By The Department Of Health, Education And Welfare Method of making unitized three leaflet heart valve
US4222126A (en) 1978-12-14 1980-09-16 The United States Of America As Represented By The Secretary Of The Department Of Health, Education & Welfare Unitized three leaflet heart valve
US4574803A (en) * 1979-01-19 1986-03-11 Karl Storz Tissue cutter
GB2056023B (en) 1979-08-06 1983-08-10 Ross D N Bodnar E Stent for a cardiac valve
US4339831A (en) 1981-03-27 1982-07-20 Medtronic, Inc. Dynamic annulus heart valve and reconstruction ring
US4470157A (en) 1981-04-27 1984-09-11 Love Jack W Tricuspid prosthetic tissue heart valve
US4345340A (en) 1981-05-07 1982-08-24 Vascor, Inc. Stent for mitral/tricuspid heart valve
SE445884B (en) 1982-04-30 1986-07-28 Medinvent Sa DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION
US4680031A (en) 1982-11-29 1987-07-14 Tascon Medical Technology Corporation Heart valve prosthesis
US4834755A (en) 1983-04-04 1989-05-30 Pfizer Hospital Products Group, Inc. Triaxially-braided fabric prosthesis
US4610688A (en) 1983-04-04 1986-09-09 Pfizer Hospital Products Group, Inc. Triaxially-braided fabric prosthesis
US4612011A (en) 1983-07-22 1986-09-16 Hans Kautzky Central occluder semi-biological heart valve
US4665906A (en) 1983-10-14 1987-05-19 Raychem Corporation Medical devices incorporating sim alloy elements
US4681908A (en) 1983-11-09 1987-07-21 Dow Corning Corporation Hard organopolysiloxane release coating
US4787899A (en) 1983-12-09 1988-11-29 Lazarus Harrison M Intraluminal graft device, system and method
US4627436A (en) 1984-03-01 1986-12-09 Innoventions Biomedical Inc. Angioplasty catheter and method for use thereof
US4592340A (en) 1984-05-02 1986-06-03 Boyles Paul W Artificial catheter means
US4979939A (en) 1984-05-14 1990-12-25 Surgical Systems & Instruments, Inc. Atherectomy system with a guide wire
US4883458A (en) 1987-02-24 1989-11-28 Surgical Systems & Instruments, Inc. Atherectomy system and method of using the same
US5007896A (en) 1988-12-19 1991-04-16 Surgical Systems & Instruments, Inc. Rotary-catheter for atherectomy
DE3426300A1 (en) 1984-07-17 1986-01-30 Doguhan Dr.med. 6000 Frankfurt Baykut TWO-WAY VALVE AND ITS USE AS A HEART VALVE PROSTHESIS
US4580568A (en) 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
US5232445A (en) 1984-11-23 1993-08-03 Tassilo Bonzel Dilatation catheter
SU1271508A1 (en) 1984-11-29 1986-11-23 Горьковский государственный медицинский институт им.С.М.Кирова Artificial heart valve
DE3530262A1 (en) * 1985-08-22 1987-02-26 Siemens Ag CIRCUIT ARRANGEMENT FOR TESTING A PASSIVE BUS NETWORK SYSTEM (CSMA / CD ACCESS METHOD)
US4662885A (en) 1985-09-03 1987-05-05 Becton, Dickinson And Company Percutaneously deliverable intravascular filter prosthesis
DE3640745A1 (en) 1985-11-30 1987-06-04 Ernst Peter Prof Dr M Strecker Catheter for producing or extending connections to or between body cavities
US4710192A (en) 1985-12-30 1987-12-01 Liotta Domingo S Diaphragm and method for occlusion of the descending thoracic aorta
US4878906A (en) 1986-03-25 1989-11-07 Servetus Partnership Endoprosthesis for repairing a damaged vessel
US4748982A (en) * 1987-01-06 1988-06-07 Advanced Cardiovascular Systems, Inc. Reinforced balloon dilatation catheter with slitted exchange sleeve and method
US4878495A (en) 1987-05-15 1989-11-07 Joseph Grayzel Valvuloplasty device with satellite expansion means
US4872874A (en) 1987-05-29 1989-10-10 Taheri Syde A Method and apparatus for transarterial aortic graft insertion and implantation
US4796629A (en) * 1987-06-03 1989-01-10 Joseph Grayzel Stiffened dilation balloon catheter device
US4819751A (en) 1987-10-16 1989-04-11 Baxter Travenol Laboratories, Inc. Valvuloplasty catheter and method
US4909252A (en) * 1988-05-26 1990-03-20 The Regents Of The Univ. Of California Perfusion balloon catheter
US5032128A (en) 1988-07-07 1991-07-16 Medtronic, Inc. Heart valve prosthesis
US4917102A (en) 1988-09-14 1990-04-17 Advanced Cardiovascular Systems, Inc. Guidewire assembly with steerable adjustable tip
US4856516A (en) 1989-01-09 1989-08-15 Cordis Corporation Endovascular stent apparatus and method
US4966604A (en) 1989-01-23 1990-10-30 Interventional Technologies Inc. Expandable atherectomy cutter with flexibly bowed blades
US4994077A (en) * 1989-04-21 1991-02-19 Dobben Richard L Artificial heart valve for implantation in a blood vessel
DK0474748T3 (en) 1989-05-31 1995-05-01 Baxter Int Biological flap prosthesis
US5609626A (en) 1989-05-31 1997-03-11 Baxter International Inc. Stent devices and support/restrictor assemblies for use in conjunction with prosthetic vascular grafts
US5047041A (en) 1989-08-22 1991-09-10 Samuels Peter B Surgical apparatus for the excision of vein valves in situ
US4986830A (en) * 1989-09-22 1991-01-22 Schneider (U.S.A.) Inc. Valvuloplasty catheter with balloon which remains stable during inflation
US5089015A (en) * 1989-11-28 1992-02-18 Promedica International Method for implanting unstented xenografts and allografts
US5059177A (en) 1990-04-19 1991-10-22 Cordis Corporation Triple lumen balloon catheter
US5411552A (en) 1990-05-18 1995-05-02 Andersen; Henning R. Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis
US5085635A (en) * 1990-05-18 1992-02-04 Cragg Andrew H Valved-tip angiographic catheter
DK124690D0 (en) 1990-05-18 1990-05-18 Henning Rud Andersen FAT PROTECTION FOR IMPLEMENTATION IN THE BODY FOR REPLACEMENT OF NATURAL FLEET AND CATS FOR USE IN IMPLEMENTING A SUCH FAT PROTECTION
US6165292A (en) 1990-12-18 2000-12-26 Advanced Cardiovascular Systems, Inc. Superelastic guiding member
US5152771A (en) 1990-12-31 1992-10-06 The Board Of Supervisors Of Louisiana State University Valve cutter for arterial by-pass surgery
US5295958A (en) 1991-04-04 1994-03-22 Shturman Cardiology Systems, Inc. Method and apparatus for in vivo heart valve decalcification
US5272909A (en) 1991-04-25 1993-12-28 Baxter International Inc. Method and device for testing venous valves
US5167628A (en) 1991-05-02 1992-12-01 Boyles Paul W Aortic balloon catheter assembly for indirect infusion of the coronary arteries
US5350398A (en) 1991-05-13 1994-09-27 Dusan Pavcnik Self-expanding filter for percutaneous insertion
US5397351A (en) * 1991-05-13 1995-03-14 Pavcnik; Dusan Prosthetic valve for percutaneous insertion
IT1245750B (en) * 1991-05-24 1994-10-14 Sorin Biomedica Emodialisi S R CARDIAC VALVE PROSTHESIS, PARTICULARLY FOR REPLACING THE AORTIC VALVE
US5370685A (en) 1991-07-16 1994-12-06 Stanford Surgical Technologies, Inc. Endovascular aortic valve replacement
US5558644A (en) 1991-07-16 1996-09-24 Heartport, Inc. Retrograde delivery catheter and method for inducing cardioplegic arrest
US5766151A (en) 1991-07-16 1998-06-16 Heartport, Inc. Endovascular system for arresting the heart
US5584803A (en) 1991-07-16 1996-12-17 Heartport, Inc. System for cardiac procedures
US6029671A (en) * 1991-07-16 2000-02-29 Heartport, Inc. System and methods for performing endovascular procedures
US6866650B2 (en) 1991-07-16 2005-03-15 Heartport, Inc. System for cardiac procedures
US20060058775A1 (en) 1991-07-16 2006-03-16 Stevens John H System and methods for performing endovascular procedures
US5795325A (en) 1991-07-16 1998-08-18 Heartport, Inc. Methods and apparatus for anchoring an occluding member
US5507767A (en) 1992-01-15 1996-04-16 Cook Incorporated Spiral stent
US5489297A (en) * 1992-01-27 1996-02-06 Duran; Carlos M. G. Bioprosthetic heart valve with absorbable stent
US5163953A (en) 1992-02-10 1992-11-17 Vince Dennis J Toroidal artificial heart valve stent
US5683448A (en) 1992-02-21 1997-11-04 Boston Scientific Technology, Inc. Intraluminal stent and graft
US7101392B2 (en) 1992-03-31 2006-09-05 Boston Scientific Corporation Tubular medical endoprostheses
WO1993022986A1 (en) 1992-05-08 1993-11-25 Schneider (Usa) Inc. Esophageal stent and delivery tool
US5332402A (en) 1992-05-12 1994-07-26 Teitelbaum George P Percutaneously-inserted cardiac valve
CA2149887A1 (en) 1992-12-30 1994-07-21 Steven J. Healy Apparatus for deploying body implantable stents
US5431676A (en) 1993-03-05 1995-07-11 Innerdyne Medical, Inc. Trocar system having expandable port
US5415633A (en) 1993-07-28 1995-05-16 Active Control Experts, Inc. Remotely steered catheterization device
KR970004845Y1 (en) 1993-09-27 1997-05-21 주식회사 수호메디테크 Stent for expanding a lumen
US5545209A (en) 1993-09-30 1996-08-13 Texas Petrodet, Inc. Controlled deployment of a medical device
US5480424A (en) * 1993-11-01 1996-01-02 Cox; James L. Heart valve replacement using flexible tubes
US5713950A (en) 1993-11-01 1998-02-03 Cox; James L. Method of replacing heart valves using flexible tubes
US5489294A (en) * 1994-02-01 1996-02-06 Medtronic, Inc. Steroid eluting stitch-in chronic cardiac lead
US5609627A (en) 1994-02-09 1997-03-11 Boston Scientific Technology, Inc. Method for delivering a bifurcated endoluminal prosthesis
US5549663A (en) 1994-03-09 1996-08-27 Cordis Corporation Endoprosthesis having graft member and exposed welded end junctions, method and procedure
DE4415359C2 (en) 1994-05-02 1997-10-23 Aesculap Ag Surgical tubular shaft instrument
US5765418A (en) 1994-05-16 1998-06-16 Medtronic, Inc. Method for making an implantable medical device from a refractory metal
US5824041A (en) 1994-06-08 1998-10-20 Medtronic, Inc. Apparatus and methods for placement and repositioning of intraluminal prostheses
JP3970341B2 (en) 1994-06-20 2007-09-05 テルモ株式会社 Vascular catheter
US5554185A (en) 1994-07-18 1996-09-10 Block; Peter C. Inflatable prosthetic cardiovascular valve for percutaneous transluminal implantation of same
US5674277A (en) 1994-12-23 1997-10-07 Willy Rusch Ag Stent for placement in a body tube
US5575818A (en) 1995-02-14 1996-11-19 Corvita Corporation Endovascular stent with locking ring
US6579314B1 (en) 1995-03-10 2003-06-17 C.R. Bard, Inc. Covered stent with encapsulated ends
US5849005A (en) 1995-06-07 1998-12-15 Heartport, Inc. Method and apparatus for minimizing the risk of air embolism when performing a procedure in a patient's thoracic cavity
US5667523A (en) 1995-04-28 1997-09-16 Impra, Inc. Dual supported intraluminal graft
US5824064A (en) 1995-05-05 1998-10-20 Taheri; Syde A. Technique for aortic valve replacement with simultaneous aortic arch graft insertion and apparatus therefor
US5580922A (en) 1995-06-06 1996-12-03 Weyerhaeuser Company Cellulose products treated with isocyanate compositions
US5716417A (en) * 1995-06-07 1998-02-10 St. Jude Medical, Inc. Integral supporting structure for bioprosthetic heart valve
DE19532846A1 (en) 1995-09-06 1997-03-13 Georg Dr Berg Valve for use in heart
US6302875B1 (en) 1996-10-11 2001-10-16 Transvascular, Inc. Catheters and related devices for forming passageways between blood vessels or other anatomical structures
US5591195A (en) * 1995-10-30 1997-01-07 Taheri; Syde Apparatus and method for engrafting a blood vessel
US6348066B1 (en) 1995-11-07 2002-02-19 Corvita Corporation Modular endoluminal stent-grafts and methods for their use
DE69526857T2 (en) 1995-11-27 2003-01-02 Schneider Europ Gmbh Buelach Stent for use in one pass
DE19546692C2 (en) 1995-12-14 2002-11-07 Hans-Reiner Figulla Self-expanding heart valve prosthesis for implantation in the human body via a catheter system
US5861028A (en) * 1996-09-09 1999-01-19 Shelhigh Inc Natural tissue heart valve and stent prosthesis and method for making the same
US5843158A (en) 1996-01-05 1998-12-01 Medtronic, Inc. Limited expansion endoluminal prostheses and methods for their use
JPH09215753A (en) 1996-02-08 1997-08-19 Schneider Usa Inc Self-expanding stent made of titanium alloy
US20020068949A1 (en) 1996-02-23 2002-06-06 Williamson Warren P. Extremely long wire fasteners for use in minimally invasive surgery and means and method for handling those fasteners
US5716370A (en) 1996-02-23 1998-02-10 Williamson, Iv; Warren Means for replacing a heart valve in a minimally invasive manner
US5746709A (en) 1996-04-25 1998-05-05 Medtronic, Inc. Intravascular pump and bypass assembly and method for using the same
US5891191A (en) 1996-04-30 1999-04-06 Schneider (Usa) Inc Cobalt-chromium-molybdenum alloy stent and stent-graft
AU3122197A (en) 1996-05-14 1997-12-05 Embol-X, Inc. Aortic occluder with associated filter and methods of use during cardiac surgery
EP0808614B1 (en) * 1996-05-23 2003-02-26 Samsung Electronics Co., Ltd. Flexible self-expandable stent and method for making the same
US5855601A (en) * 1996-06-21 1999-01-05 The Trustees Of Columbia University In The City Of New York Artificial heart valve and method and device for implanting the same
US6702851B1 (en) 1996-09-06 2004-03-09 Joseph A. Chinn Prosthetic heart valve with surface modification
US6764509B2 (en) 1996-09-06 2004-07-20 Carbomedics Inc. Prosthetic heart valve with surface modification
US5968068A (en) 1996-09-12 1999-10-19 Baxter International Inc. Endovascular delivery system
BR9706814A (en) * 1996-10-01 1999-12-28 Numed Inc Radially expandable stent type device.
US6325826B1 (en) 1998-01-14 2001-12-04 Advanced Stent Technologies, Inc. Extendible stent apparatus
US5749890A (en) 1996-12-03 1998-05-12 Shaknovich; Alexander Method and system for stent placement in ostial lesions
NL1004827C2 (en) 1996-12-18 1998-06-19 Surgical Innovations Vof Device for regulating blood circulation.
EP0850607A1 (en) 1996-12-31 1998-07-01 Cordis Corporation Valve prosthesis for implantation in body channels
GB9701479D0 (en) * 1997-01-24 1997-03-12 Aortech Europ Ltd Heart valve
US6241757B1 (en) 1997-02-04 2001-06-05 Solco Surgical Instrument Co., Ltd. Stent for expanding body's lumen
WO1998036790A1 (en) 1997-02-19 1998-08-27 Condado Medical Devices Corporation Multi-purpose catheters, catheter systems, and radiation treatment
US5830229A (en) 1997-03-07 1998-11-03 Micro Therapeutics Inc. Hoop stent
US5851232A (en) 1997-03-15 1998-12-22 Lois; William A. Venous stent
US5824053A (en) 1997-03-18 1998-10-20 Endotex Interventional Systems, Inc. Helical mesh endoprosthesis and methods of use
WO1998047447A1 (en) 1997-04-23 1998-10-29 Dubrul William R Bifurcated stent and distal protection system
US5957949A (en) 1997-05-01 1999-09-28 World Medical Manufacturing Corp. Percutaneous placement valve stent
US6162245A (en) 1997-05-07 2000-12-19 Iowa-India Investments Company Limited Stent valve and stent graft
US6245102B1 (en) 1997-05-07 2001-06-12 Iowa-India Investments Company Ltd. Stent, stent graft and stent valve
US5855597A (en) * 1997-05-07 1999-01-05 Iowa-India Investments Co. Limited Stent valve and stent graft for percutaneous surgery
US5911734A (en) 1997-05-08 1999-06-15 Embol-X, Inc. Percutaneous catheter and guidewire having filter and medical device deployment capabilities
US6258120B1 (en) 1997-12-23 2001-07-10 Embol-X, Inc. Implantable cerebral protection device and methods of use
US6855143B2 (en) 1997-06-13 2005-02-15 Arthrocare Corporation Electrosurgical systems and methods for recanalization of occluded body lumens
US5906619A (en) 1997-07-24 1999-05-25 Medtronic, Inc. Disposable delivery device for endoluminal prostheses
US5984957A (en) 1997-08-12 1999-11-16 Schneider (Usa) Inc Radially expanded prostheses with axial diameter control
WO1999012483A1 (en) 1997-09-11 1999-03-18 Genzyme Corporation Articulating endoscopic implant rotator surgical apparatus and method for using same
US6056722A (en) 1997-09-18 2000-05-02 Iowa-India Investments Company Limited Of Douglas Delivery mechanism for balloons, drugs, stents and other physical/mechanical agents and methods of use
US6361545B1 (en) 1997-09-26 2002-03-26 Cardeon Corporation Perfusion filter catheter
US5925063A (en) 1997-09-26 1999-07-20 Khosravi; Farhad Coiled sheet valve, filter or occlusive device and methods of use
EP1625833A3 (en) * 1997-11-25 2010-09-22 TriVascular2, Inc. Layered endovascular graft
US6248116B1 (en) 1997-12-16 2001-06-19 B. Braun Celsa Medical treatment of a diseased anatomical duct
US6530952B2 (en) 1997-12-29 2003-03-11 The Cleveland Clinic Foundation Bioprosthetic cardiovascular valve system
AU2011699A (en) 1997-12-29 1999-07-19 Ivan Vesely System for minimally invasive insertion of a bioprosthetic heart valve
US5944738A (en) 1998-02-06 1999-08-31 Aga Medical Corporation Percutaneous catheter directed constricting occlusion device
WO1999039649A1 (en) 1998-02-10 1999-08-12 Dubrul William R Occlusion, anchoring, tensioning and flow direction apparatus and methods for use
JP2002502626A (en) 1998-02-10 2002-01-29 アーテミス・メディカル・インコーポレイテッド Supplementary device and method of using the same
US6059809A (en) 1998-02-16 2000-05-09 Medicorp, S.A. Protective angioplasty device
EP0943300A1 (en) 1998-03-17 1999-09-22 Medicorp S.A. Reversible action endoprosthesis delivery device.
US6074418A (en) 1998-04-20 2000-06-13 St. Jude Medical, Inc. Driver tool for heart valve prosthesis fasteners
US6218662B1 (en) 1998-04-23 2001-04-17 Western Atlas International, Inc. Downhole carbon dioxide gas analyzer
US6450989B2 (en) 1998-04-27 2002-09-17 Artemis Medical, Inc. Dilating and support apparatus with disease inhibitors and methods for use
JP4399585B2 (en) 1998-06-02 2010-01-20 クック インコーポレイティド Multi-sided medical device
US7452371B2 (en) 1999-06-02 2008-11-18 Cook Incorporated Implantable vascular device
US6630001B2 (en) 1998-06-24 2003-10-07 International Heart Institute Of Montana Foundation Compliant dehyrated tissue for implantation and process of making the same
US6254636B1 (en) 1998-06-26 2001-07-03 St. Jude Medical, Inc. Single suture biological tissue aortic stentless valve
US6159239A (en) 1998-08-14 2000-12-12 Prodesco, Inc. Woven stent/graft structure
US6179860B1 (en) 1998-08-19 2001-01-30 Artemis Medical, Inc. Target tissue localization device and method
US6203550B1 (en) 1998-09-30 2001-03-20 Medtronic, Inc. Disposable delivery device for endoluminal prostheses
US6475239B1 (en) 1998-10-13 2002-11-05 Sulzer Carbomedics Inc. Method for making polymer heart valves with leaflets having uncut free edges
US6051014A (en) 1998-10-13 2000-04-18 Embol-X, Inc. Percutaneous filtration catheter for valve repair surgery and methods of use
US6146366A (en) 1998-11-03 2000-11-14 Ras Holding Corp Device for the treatment of macular degeneration and other eye disorders
DE19857887B4 (en) 1998-12-15 2005-05-04 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Anchoring support for a heart valve prosthesis
FR2788217A1 (en) 1999-01-12 2000-07-13 Brice Letac PROSTHETIC VALVE IMPLANTABLE BY CATHETERISM, OR SURGICAL
US6350277B1 (en) * 1999-01-15 2002-02-26 Scimed Life Systems, Inc. Stents with temporary retaining bands
US6558418B2 (en) 1999-01-26 2003-05-06 Edwards Lifesciences Corporation Flexible heart valve
US6736845B2 (en) * 1999-01-26 2004-05-18 Edwards Lifesciences Corporation Holder for flexible heart valve
US6896690B1 (en) 2000-01-27 2005-05-24 Viacor, Inc. Cardiac valve procedure methods and devices
US7018401B1 (en) * 1999-02-01 2006-03-28 Board Of Regents, The University Of Texas System Woven intravascular devices and methods for making the same and apparatus for delivery of the same
DK1148839T3 (en) 1999-02-01 2008-12-15 Univ Texas Woven two-branched and three-branched stents and methods of making them
DE19904975A1 (en) 1999-02-06 2000-09-14 Impella Cardiotech Ag Device for intravascular heart valve surgery
US6425916B1 (en) 1999-02-10 2002-07-30 Michi E. Garrison Methods and devices for implanting cardiac valves
AU3999700A (en) 1999-02-12 2000-08-29 Johns Hopkins University, The Venous valve implant bioprosthesis and endovascular treatment for venous insufficiency
US6110201A (en) 1999-02-18 2000-08-29 Venpro Bifurcated biological pulmonary valved conduit
DE19907646A1 (en) 1999-02-23 2000-08-24 Georg Berg Valve for blood vessels uses flap holders and counterpart holders on stent to latch together in place and all channeled for guide wire.
US6210408B1 (en) 1999-02-24 2001-04-03 Scimed Life Systems, Inc. Guide wire system for RF recanalization of vascular blockages
IL128938A0 (en) * 1999-03-11 2000-02-17 Mind Guard Ltd Implantable stroke treating device
US6673089B1 (en) * 1999-03-11 2004-01-06 Mindguard Ltd. Implantable stroke treating device
US7147663B1 (en) 1999-04-23 2006-12-12 St. Jude Medical Atg, Inc. Artificial heart valve attachment apparatus and methods
US6309417B1 (en) 1999-05-12 2001-10-30 Paul A. Spence Heart valve and apparatus for replacement thereof
US6790229B1 (en) 1999-05-25 2004-09-14 Eric Berreklouw Fixing device, in particular for fixing to vascular wall tissue
EP1057460A1 (en) 1999-06-01 2000-12-06 Numed, Inc. Replacement valve assembly and method of implanting same
US6241763B1 (en) 1999-06-08 2001-06-05 William J. Drasler In situ venous valve device and method of formation
WO2001005331A1 (en) 1999-07-16 2001-01-25 Biocompatibles Ltd Braided stent
US6371970B1 (en) 1999-07-30 2002-04-16 Incept Llc Vascular filter having articulation region and methods of use in the ascending aorta
US6299637B1 (en) 1999-08-20 2001-10-09 Samuel M. Shaolian Transluminally implantable venous valve
EP1229865B1 (en) 1999-09-10 2010-11-17 Cook Incorporated Endovascular treatment for chronic venous insufficiency
US6371983B1 (en) 1999-10-04 2002-04-16 Ernest Lane Bioprosthetic heart valve
FR2799364B1 (en) * 1999-10-12 2001-11-23 Jacques Seguin MINIMALLY INVASIVE CANCELING DEVICE
US6352708B1 (en) 1999-10-14 2002-03-05 The International Heart Institute Of Montana Foundation Solution and method for treating autologous tissue for implant operation
US6440164B1 (en) 1999-10-21 2002-08-27 Scimed Life Systems, Inc. Implantable prosthetic valve
US6585758B1 (en) 1999-11-16 2003-07-01 Scimed Life Systems, Inc. Multi-section filamentary endoluminal stent
FR2815844B1 (en) 2000-10-31 2003-01-17 Jacques Seguin TUBULAR SUPPORT FOR THE PERCUTANEOUS POSITIONING OF A REPLACEMENT HEART VALVE
US7018406B2 (en) 1999-11-17 2006-03-28 Corevalve Sa Prosthetic valve for transluminal delivery
FR2800984B1 (en) 1999-11-17 2001-12-14 Jacques Seguin DEVICE FOR REPLACING A HEART VALVE PERCUTANEOUSLY
US8579966B2 (en) 1999-11-17 2013-11-12 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US20070043435A1 (en) * 1999-11-17 2007-02-22 Jacques Seguin Non-cylindrical prosthetic valve system for transluminal delivery
US6936066B2 (en) 1999-11-19 2005-08-30 Advanced Bio Prosthetic Surfaces, Ltd. Complaint implantable medical devices and methods of making same
US6849085B2 (en) 1999-11-19 2005-02-01 Advanced Bio Prosthetic Surfaces, Ltd. Self-supporting laminated films, structural materials and medical devices manufactured therefrom and method of making same
US6379383B1 (en) 1999-11-19 2002-04-30 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal device exhibiting improved endothelialization and method of manufacture thereof
US7300457B2 (en) 1999-11-19 2007-11-27 Advanced Bio Prosthetic Surfaces, Ltd. Self-supporting metallic implantable grafts, compliant implantable medical devices and methods of making same
US7195641B2 (en) * 1999-11-19 2007-03-27 Advanced Bio Prosthetic Surfaces, Ltd. Valvular prostheses having metal or pseudometallic construction and methods of manufacture
US6458153B1 (en) 1999-12-31 2002-10-01 Abps Venture One, Ltd. Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof
NL1014095C2 (en) 2000-01-17 2001-07-18 Cornelis Hendrikus Anna Witten Implant valve for implantation into a blood vessel.
WO2001053559A1 (en) 2000-01-24 2001-07-26 Smart Therapeutics, Inc. Thin-film shape memory alloy device and method
KR20020082217A (en) 2000-01-27 2002-10-30 쓰리에프 쎄러퓨틱스, 인코포레이티드 Prosthetic Heart Valve
US6929653B2 (en) 2000-12-15 2005-08-16 Medtronic, Inc. Apparatus and method for replacing aortic valve
US7749245B2 (en) * 2000-01-27 2010-07-06 Medtronic, Inc. Cardiac valve procedure methods and devices
US6872226B2 (en) * 2001-01-29 2005-03-29 3F Therapeutics, Inc. Method of cutting material for use in implantable medical device
US6989028B2 (en) * 2000-01-31 2006-01-24 Edwards Lifesciences Ag Medical system and method for remodeling an extravascular tissue structure
US6398807B1 (en) 2000-01-31 2002-06-04 Scimed Life Systems, Inc. Braided branching stent, method for treating a lumen therewith, and process for manufacture therefor
US6402781B1 (en) 2000-01-31 2002-06-11 Mitralife Percutaneous mitral annuloplasty and cardiac reinforcement
US7507252B2 (en) 2000-01-31 2009-03-24 Edwards Lifesciences Ag Adjustable transluminal annuloplasty system
US6622604B1 (en) 2000-01-31 2003-09-23 Scimed Life Systems, Inc. Process for manufacturing a braided bifurcated stent
PL211860B1 (en) 2000-01-31 2012-07-31 Cook Biotech Inc Valve stent system
US6652571B1 (en) 2000-01-31 2003-11-25 Scimed Life Systems, Inc. Braided, branched, implantable device and processes for manufacture thereof
US6821297B2 (en) 2000-02-02 2004-11-23 Robert V. Snyders Artificial heart valve, implantation instrument and method therefor
US6797002B2 (en) 2000-02-02 2004-09-28 Paul A. Spence Heart valve repair apparatus and methods
DE10010074B4 (en) 2000-02-28 2005-04-14 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Device for fastening and anchoring heart valve prostheses
DE10010073B4 (en) * 2000-02-28 2005-12-22 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Anchoring for implantable heart valve prostheses
US6468303B1 (en) 2000-03-27 2002-10-22 Aga Medical Corporation Retrievable self expanding shunt
US6454799B1 (en) 2000-04-06 2002-09-24 Edwards Lifesciences Corporation Minimally-invasive heart valves and methods of use
ATE416718T1 (en) 2000-05-04 2008-12-15 Univ Oregon Health & Science ENDOVASCULAR STENT GRAFT
US20020057440A1 (en) 2000-05-19 2002-05-16 Michael Weiner Document with embedded information
SE522805C2 (en) 2000-06-22 2004-03-09 Jan Otto Solem Stent Application System
US6527800B1 (en) 2000-06-26 2003-03-04 Rex Medical, L.P. Vascular device and method for valve leaflet apposition
US6695878B2 (en) * 2000-06-26 2004-02-24 Rex Medical, L.P. Vascular device for valve leaflet apposition
US6676698B2 (en) * 2000-06-26 2004-01-13 Rex Medicol, L.P. Vascular device with valve for approximating vessel wall
EP1401358B1 (en) 2000-06-30 2016-08-17 Medtronic, Inc. Apparatus for performing a procedure on a cardiac valve
AU2001273088A1 (en) * 2000-06-30 2002-01-30 Viacor Incorporated Intravascular filter with debris entrapment mechanism
US6419696B1 (en) 2000-07-06 2002-07-16 Paul A. Spence Annuloplasty devices and related heart valve repair methods
WO2002019951A1 (en) 2000-09-07 2002-03-14 Viacor, Inc. Fixation band for affixing a prosthetic heart valve to tissue
US20060142848A1 (en) 2000-09-12 2006-06-29 Shlomo Gabbay Extra-anatomic aortic valve placement
WO2002022054A1 (en) 2000-09-12 2002-03-21 Gabbay S Valvular prosthesis and method of using same
US7510572B2 (en) 2000-09-12 2009-03-31 Shlomo Gabbay Implantation system for delivery of a heart valve prosthesis
WO2004030568A2 (en) * 2002-10-01 2004-04-15 Ample Medical, Inc. Device and method for repairing a native heart valve leaflet
US6461382B1 (en) 2000-09-22 2002-10-08 Edwards Lifesciences Corporation Flexible heart valve having moveable commissures
US6932838B2 (en) 2000-09-29 2005-08-23 Tricardia, Llc Venous valvuloplasty device and method
JP5100951B2 (en) 2000-09-29 2012-12-19 コーディス・コーポレイション Coated medical device
DE10049812B4 (en) 2000-10-09 2004-06-03 Universitätsklinikum Freiburg Device for filtering out macroscopic particles from the bloodstream during local removal of an aortic valve on the human or animal heart
DE10049813C1 (en) 2000-10-09 2002-04-18 Universitaetsklinikum Freiburg Instrument for the local removal of built-up matter at an aortic valve, in a human or animal heart, is a hollow catheter with a cutting unit at the far end within a closure cap for minimum invasion
DE10049814B4 (en) 2000-10-09 2006-10-19 Universitätsklinikum Freiburg Device for supporting surgical procedures within a vessel, in particular for minimally invasive explantation and implantation of heart valves
DE10049815B4 (en) 2000-10-09 2005-10-13 Universitätsklinikum Freiburg Device for local ablation of an aortic valve on the human or animal heart
AU2002220270A1 (en) 2000-10-27 2002-05-06 Viacor, Inc. Intracardiovascular access (icvatm) system
JP4180382B2 (en) 2000-11-07 2008-11-12 アーテミス・メディカル・インコーポレイテッド Tissue separation assembly and tissue separation method
US6482228B1 (en) 2000-11-14 2002-11-19 Troy R. Norred Percutaneous aortic valve replacement
US6974476B2 (en) * 2003-05-05 2005-12-13 Rex Medical, L.P. Percutaneous aortic valve
US6494909B2 (en) 2000-12-01 2002-12-17 Prodesco, Inc. Endovascular valve
US20020072789A1 (en) 2000-12-12 2002-06-13 Hackett Steven S. Soc lubricant filler port
US20040093075A1 (en) 2000-12-15 2004-05-13 Titus Kuehne Stent with valve and method of use thereof
US6562058B2 (en) 2001-03-02 2003-05-13 Jacques Seguin Intravascular filter system
US6488704B1 (en) 2001-05-07 2002-12-03 Biomed Solutions, Llc Implantable particle measuring apparatus
US6503272B2 (en) * 2001-03-21 2003-01-07 Cordis Corporation Stent-based venous valves
US6733525B2 (en) 2001-03-23 2004-05-11 Edwards Lifesciences Corporation Rolled minimally-invasive heart valves and methods of use
US7374571B2 (en) 2001-03-23 2008-05-20 Edwards Lifesciences Corporation Rolled minimally-invasive heart valves and methods of manufacture
US7556646B2 (en) 2001-09-13 2009-07-07 Edwards Lifesciences Corporation Methods and apparatuses for deploying minimally-invasive heart valves
US6613077B2 (en) 2001-03-27 2003-09-02 Scimed Life Systems, Inc. Stent with controlled expansion
DE10121210B4 (en) 2001-04-30 2005-11-17 Universitätsklinikum Freiburg Anchoring element for the intraluminal anchoring of a heart valve replacement and method for its production
US6682558B2 (en) * 2001-05-10 2004-01-27 3F Therapeutics, Inc. Delivery system for a stentless valve bioprosthesis
US6663663B2 (en) 2001-05-14 2003-12-16 M.I. Tech Co., Ltd. Stent
KR100393548B1 (en) 2001-06-05 2003-08-02 주식회사 엠아이텍 Stent
US8771302B2 (en) 2001-06-29 2014-07-08 Medtronic, Inc. Method and apparatus for resecting and replacing an aortic valve
US7544206B2 (en) 2001-06-29 2009-06-09 Medtronic, Inc. Method and apparatus for resecting and replacing an aortic valve
US7201761B2 (en) 2001-06-29 2007-04-10 Medtronic, Inc. Method and apparatus for resecting and replacing an aortic valve
FR2826863B1 (en) 2001-07-04 2003-09-26 Jacques Seguin ASSEMBLY FOR PLACING A PROSTHETIC VALVE IN A BODY CONDUIT
US7377938B2 (en) 2001-07-19 2008-05-27 The Cleveland Clinic Foundation Prosthetic cardiac value and method for making same
FR2828091B1 (en) * 2001-07-31 2003-11-21 Seguin Jacques ASSEMBLY ALLOWING THE PLACEMENT OF A PROTHETIC VALVE IN A BODY DUCT
FR2828263B1 (en) * 2001-08-03 2007-05-11 Philipp Bonhoeffer DEVICE FOR IMPLANTATION OF AN IMPLANT AND METHOD FOR IMPLANTATION OF THE DEVICE
US6896002B2 (en) * 2001-08-21 2005-05-24 Scimed Life Systems, Inc Pressure transducer protection valve
US7097659B2 (en) 2001-09-07 2006-08-29 Medtronic, Inc. Fixation band for affixing a prosthetic heart valve to tissue
US20030065386A1 (en) 2001-09-28 2003-04-03 Weadock Kevin Shaun Radially expandable endoprosthesis device with two-stage deployment
US7172572B2 (en) 2001-10-04 2007-02-06 Boston Scientific Scimed, Inc. Manifold system for a medical device
US6976974B2 (en) 2002-10-23 2005-12-20 Scimed Life Systems, Inc. Rotary manifold syringe
US20080021552A1 (en) * 2001-10-09 2008-01-24 Shlomo Gabbay Apparatus To Facilitate Implantation
US6893460B2 (en) * 2001-10-11 2005-05-17 Percutaneous Valve Technologies Inc. Implantable prosthetic valve
GB0125925D0 (en) 2001-10-29 2001-12-19 Univ Glasgow Mitral valve prosthesis
US20030130729A1 (en) 2002-01-04 2003-07-10 David Paniagua Percutaneously implantable replacement heart valve device and method of making same
US8308797B2 (en) 2002-01-04 2012-11-13 Colibri Heart Valve, LLC Percutaneously implantable replacement heart valve device and method of making same
US6730377B2 (en) 2002-01-23 2004-05-04 Scimed Life Systems, Inc. Balloons made from liquid crystal polymer blends
US6689144B2 (en) * 2002-02-08 2004-02-10 Scimed Life Systems, Inc. Rapid exchange catheter and methods for delivery of vaso-occlusive devices
US6752828B2 (en) 2002-04-03 2004-06-22 Scimed Life Systems, Inc. Artificial valve
US7125418B2 (en) 2002-04-16 2006-10-24 The International Heart Institute Of Montana Foundation Sigmoid valve and method for its percutaneous implantation
US7105016B2 (en) 2002-04-23 2006-09-12 Medtronic Vascular, Inc. Integrated mechanical handle with quick slide mechanism
US8721713B2 (en) 2002-04-23 2014-05-13 Medtronic, Inc. System for implanting a replacement valve
US20030199971A1 (en) 2002-04-23 2003-10-23 Numed, Inc. Biological replacement valve assembly
AU2003234505A1 (en) 2002-05-03 2003-11-17 The General Hospital Corporation Involuted endovascular valve and method of construction
US6830575B2 (en) 2002-05-08 2004-12-14 Scimed Life Systems, Inc. Method and device for providing full protection to a stent
US7141064B2 (en) 2002-05-08 2006-11-28 Edwards Lifesciences Corporation Compressed tissue for heart valve leaflets
MXPA04011144A (en) 2002-05-10 2005-08-16 Johnson & Johnson Method of making a medical device having a thin wall tubular membrane over a structural frame.
US20030225445A1 (en) 2002-05-14 2003-12-04 Derus Patricia M. Surgical stent delivery devices and methods
US20040117004A1 (en) 2002-05-16 2004-06-17 Osborne Thomas A. Stent and method of forming a stent with integral barbs
EP1513440A2 (en) 2002-05-30 2005-03-16 The Board of Trustees of The Leland Stanford Junior University Apparatus and method for coronary sinus access
DE10362367B3 (en) 2002-08-13 2022-02-24 Jenavalve Technology Inc. Device for anchoring and aligning prosthetic heart valves
US7041132B2 (en) * 2002-08-16 2006-05-09 3F Therapeutics, Inc, Percutaneously delivered heart valve and delivery means thereof
US7217287B2 (en) 2002-08-28 2007-05-15 Heart Leaflet Technologies, Inc. Method of treating diseased valve
US6875231B2 (en) 2002-09-11 2005-04-05 3F Therapeutics, Inc. Percutaneously deliverable heart valve
US7105013B2 (en) 2002-09-30 2006-09-12 Advanced Cardiovascular Systems, Inc. Protective sleeve assembly for a balloon catheter
CA2502967A1 (en) 2002-10-24 2004-05-06 Boston Scientific Limited Venous valve apparatus and method
CA2505137A1 (en) 2002-11-08 2004-05-21 Jacques Seguin Endoprosthesis for vascular bifurcation
WO2004043273A2 (en) 2002-11-13 2004-05-27 Rosengart Todd K Apparatus and method for cutting a heart valve
US7141061B2 (en) 2002-11-14 2006-11-28 Synecor, Llc Photocurable endoprosthesis system
FR2847155B1 (en) 2002-11-20 2005-08-05 Younes Boudjemline METHOD FOR MANUFACTURING A MEDICAL IMPLANT WITH ADJUSTED STRUCTURE AND IMPLANT OBTAINED THEREBY
AU2003283792A1 (en) 2002-11-29 2004-06-23 Mindguard Ltd. Braided intraluminal device for stroke prevention
US8551162B2 (en) 2002-12-20 2013-10-08 Medtronic, Inc. Biologically implantable prosthesis
US6830585B1 (en) 2003-01-14 2004-12-14 3F Therapeutics, Inc. Percutaneously deliverable heart valve and methods of implantation
US7399315B2 (en) 2003-03-18 2008-07-15 Edwards Lifescience Corporation Minimally-invasive heart valve with cusp positioners
US20050107871A1 (en) 2003-03-30 2005-05-19 Fidel Realyvasquez Apparatus and methods for valve repair
US20060271081A1 (en) 2003-03-30 2006-11-30 Fidel Realyvasquez Apparatus and methods for valve repair
WO2004089253A1 (en) * 2003-04-01 2004-10-21 Cook Incorporated Percutaneously deployed vascular valves
US7530995B2 (en) 2003-04-17 2009-05-12 3F Therapeutics, Inc. Device for reduction of pressure effects of cardiac tricuspid valve regurgitation
US7175656B2 (en) * 2003-04-18 2007-02-13 Alexander Khairkhahan Percutaneous transcatheter heart valve replacement
US20040210240A1 (en) 2003-04-21 2004-10-21 Sean Saint Method and repair device for treating mitral valve insufficiency
US8221492B2 (en) 2003-04-24 2012-07-17 Cook Medical Technologies Artificial valve prosthesis with improved flow dynamics
US7591832B2 (en) 2003-04-24 2009-09-22 Medtronic, Inc. Expandable guide sheath and apparatus with distal protection and methods for use
US8388628B2 (en) 2003-04-24 2013-03-05 Medtronic, Inc. Expandable sheath for delivering instruments and agents into a body lumen and methods for use
DE602004023350D1 (en) * 2003-04-30 2009-11-12 Medtronic Vascular Inc Percutaneous inserted provisional valve
US20040267357A1 (en) 2003-04-30 2004-12-30 Allen Jeffrey W. Cardiac valve modification method and device
DE602004021799D1 (en) 2003-05-19 2009-08-13 Cook Inc IMPLANTABLE MEDICAL DEVICE WITH LIMITED EXPANSION
ATE481057T1 (en) 2003-05-28 2010-10-15 Cook Inc VALVE PROSTHESIS WITH VESSEL FIXING DEVICE
WO2005004753A1 (en) 2003-06-09 2005-01-20 3F Therapeutics, Inc. Atrioventricular heart valve and minimally invasive delivery systems thereof
WO2004112651A2 (en) 2003-06-20 2004-12-29 Medtronic Vascular, Inc. Chordae tendinae girdle
US7316706B2 (en) * 2003-06-20 2008-01-08 Medtronic Vascular, Inc. Tensioning device, system, and method for treating mitral valve regurgitation
WO2004112652A2 (en) 2003-06-20 2004-12-29 Medtronic Vascular, Inc. Device, system, and method for contracting tissue in a mammalian body
US20040260394A1 (en) 2003-06-20 2004-12-23 Medtronic Vascular, Inc. Cardiac valve annulus compressor system
US20060282161A1 (en) 2003-06-20 2006-12-14 Medtronic Vascular, Inc. Valve annulus reduction system
US7201772B2 (en) 2003-07-08 2007-04-10 Ventor Technologies, Ltd. Fluid flow prosthetic device
BRPI0412362A (en) 2003-07-08 2006-09-05 Ventor Technologies Ltd prosthetic implant devices particularly for transarterial transport in the treatment of aortic stenoses and implantation methods for such devices
WO2005018507A2 (en) 2003-07-18 2005-03-03 Ev3 Santa Rosa, Inc. Remotely activated mitral annuloplasty system and methods
CA2533353A1 (en) * 2003-07-21 2005-02-03 The Trustees Of The University Of Pennsylvania Percutaneous heart valve
DE10334868B4 (en) 2003-07-29 2013-10-17 Pfm Medical Ag Implantable device as a replacement organ valve, its manufacturing process and basic body and membrane element for it
WO2005011535A2 (en) 2003-07-31 2005-02-10 Cook Incorporated Prosthetic valve for implantation in a body vessel
EP1659992B1 (en) * 2003-07-31 2013-03-27 Cook Medical Technologies LLC Prosthetic valve devices and methods of making such devices
DE10340265A1 (en) * 2003-08-29 2005-04-07 Sievers, Hans-Hinrich, Prof. Dr.med. Prosthesis for the replacement of the aortic and / or mitral valve of the heart
US20050049692A1 (en) 2003-09-02 2005-03-03 Numamoto Michael J. Medical device for reduction of pressure effects of cardiac tricuspid valve regurgitation
US8535344B2 (en) 2003-09-12 2013-09-17 Rubicon Medical, Inc. Methods, systems, and devices for providing embolic protection and removing embolic material
WO2005032421A2 (en) 2003-09-15 2005-04-14 Medtronic Vascular, Inc. Apparatus and method for elongation of a papillary muscle
EG24012A (en) 2003-09-24 2008-03-23 Wael Mohamed Nabil Lotfy Valved balloon stent
JP3726266B2 (en) 2003-10-02 2005-12-14 朝日インテック株式会社 Medical guidewire tip structure
US20060259137A1 (en) 2003-10-06 2006-11-16 Jason Artof Minimally invasive valve replacement system
US20050096738A1 (en) 2003-10-06 2005-05-05 Cali Douglas S. Minimally invasive valve replacement system
US10219899B2 (en) 2004-04-23 2019-03-05 Medtronic 3F Therapeutics, Inc. Cardiac valve replacement systems
WO2005046528A1 (en) 2003-10-06 2005-05-26 3F Therapeutics, Inc. Minimally invasive valve replacement system
US7842084B2 (en) 2005-06-21 2010-11-30 3F Therapeutics, Inc. Method and systems for sizing, folding, holding, and delivering a heart valve prosthesis
US7604650B2 (en) 2003-10-06 2009-10-20 3F Therapeutics, Inc. Method and assembly for distal embolic protection
DE602004026756D1 (en) 2003-10-15 2010-06-02 Cook Inc HOLDING DEVICE FOR A PROSTHESIS SYSTEM
US7419498B2 (en) 2003-10-21 2008-09-02 Nmt Medical, Inc. Quick release knot attachment system
US7347869B2 (en) 2003-10-31 2008-03-25 Cordis Corporation Implantable valvular prosthesis
US7070616B2 (en) 2003-10-31 2006-07-04 Cordis Corporation Implantable valvular prosthesis
US7955384B2 (en) * 2003-11-12 2011-06-07 Medtronic Vascular, Inc. Coronary sinus approach for repair of mitral valve regurgitation
EP1689329A2 (en) 2003-11-12 2006-08-16 Medtronic Vascular, Inc. Cardiac valve annulus reduction system
WO2005046530A1 (en) 2003-11-12 2005-05-26 Medtronic Vascular, Inc. Coronary sinus approach for repair of mitral valve reguritation
WO2005048883A1 (en) 2003-11-13 2005-06-02 Fidel Realyvasquez Methods and apparatus for valve repair
US7186265B2 (en) 2003-12-10 2007-03-06 Medtronic, Inc. Prosthetic cardiac valves and systems and methods for implanting thereof
US7959666B2 (en) 2003-12-23 2011-06-14 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a heart valve
US20050137686A1 (en) 2003-12-23 2005-06-23 Sadra Medical, A Delaware Corporation Externally expandable heart valve anchor and method
US8603160B2 (en) * 2003-12-23 2013-12-10 Sadra Medical, Inc. Method of using a retrievable heart valve anchor with a sheath
US8182528B2 (en) 2003-12-23 2012-05-22 Sadra Medical, Inc. Locking heart valve anchor
US7329279B2 (en) * 2003-12-23 2008-02-12 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US9526609B2 (en) 2003-12-23 2016-12-27 Boston Scientific Scimed, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US8840663B2 (en) 2003-12-23 2014-09-23 Sadra Medical, Inc. Repositionable heart valve method
US20050149181A1 (en) 2004-01-07 2005-07-07 Medtronic, Inc. Bileaflet prosthetic valve and method of manufacture
WO2005069850A2 (en) 2004-01-15 2005-08-04 Macoviak John A Trestle heart valve replacement
WO2005076973A2 (en) 2004-02-05 2005-08-25 Children's Medical Center Corporation Transcatheter delivery of a replacement heart valve
EP1722711A4 (en) 2004-02-27 2009-12-02 Aortx Inc Prosthetic heart valve delivery systems and methods
ITTO20040135A1 (en) 2004-03-03 2004-06-03 Sorin Biomedica Cardio Spa CARDIAC VALVE PROSTHESIS
US20050203549A1 (en) 2004-03-09 2005-09-15 Fidel Realyvasquez Methods and apparatus for off pump aortic valve replacement with a valve prosthesis
JP2007529273A (en) 2004-03-15 2007-10-25 メドトロニック ヴァスキュラー インコーポレイテッド Stent resistant to radial crush
US20050222674A1 (en) 2004-03-31 2005-10-06 Med Institute, Inc. Endoluminal graft with a prosthetic valve
JP5242159B2 (en) * 2004-06-16 2013-07-24 マシーン ソリューションズ インコーポレイテッド Tissue prosthesis processing technology
US7462191B2 (en) * 2004-06-30 2008-12-09 Edwards Lifesciences Pvt, Inc. Device and method for assisting in the implantation of a prosthetic valve
EP1786367B1 (en) 2004-08-27 2013-04-03 Cook Medical Technologies LLC Placement of multiple intraluminal medical devices within a body vessel
FR2874813B1 (en) 2004-09-07 2007-06-22 Perouse Soc Par Actions Simpli VALVULAR PROSTHESIS
US20060052867A1 (en) 2004-09-07 2006-03-09 Medtronic, Inc Replacement prosthetic heart valve, system and method of implant
US6951571B1 (en) 2004-09-30 2005-10-04 Rohit Srivastava Valve implanting device
US20060089711A1 (en) 2004-10-27 2006-04-27 Medtronic Vascular, Inc. Multifilament anchor for reducing a compass of a lumen or structure in mammalian body
US7458987B2 (en) 2004-10-29 2008-12-02 Cook Incorporated Vascular valves having implanted and target configurations and methods of preparing the same
US8562672B2 (en) 2004-11-19 2013-10-22 Medtronic, Inc. Apparatus for treatment of cardiac valves and method of its manufacture
WO2006054107A2 (en) * 2004-11-19 2006-05-26 Medtronic Inc. Method and apparatus for treatment of cardiac valves
DE102005003632A1 (en) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Catheter for the transvascular implantation of heart valve prostheses
CA2593652A1 (en) * 2005-01-21 2006-08-17 Innovia, Llc Stent-valve and deployment catheter for use therewith
ITTO20050074A1 (en) * 2005-02-10 2006-08-11 Sorin Biomedica Cardio Srl CARDIAC VALVE PROSTHESIS
ES2558534T3 (en) * 2005-02-18 2016-02-05 The Cleveland Clinic Foundation Device to replace a heart valve
US7955385B2 (en) 2005-02-28 2011-06-07 Medtronic Vascular, Inc. Device, system, and method for aiding valve annuloplasty
FR2883721B1 (en) * 2005-04-05 2007-06-22 Perouse Soc Par Actions Simpli NECESSARY TO BE IMPLANTED IN A BLOOD CIRCULATION CONDUIT, AND ASSOCIATED TUBULAR ENDOPROTHESIS
US20060276882A1 (en) 2005-04-11 2006-12-07 Cook Incorporated Medical device including remodelable material attached to frame
US7914569B2 (en) 2005-05-13 2011-03-29 Medtronics Corevalve Llc Heart valve prosthesis and methods of manufacture and use
US20060271172A1 (en) 2005-05-16 2006-11-30 Hassan Tehrani Minimally Invasive Aortic Valve Replacement
CN101180010B (en) * 2005-05-24 2010-12-01 爱德华兹生命科学公司 Rapid deployment prosthetic heart valve
CN101247773B (en) 2005-05-27 2010-12-15 心叶科技公司 Stentless support structure
US8663312B2 (en) 2005-05-27 2014-03-04 Hlt, Inc. Intravascular cuff
US7780723B2 (en) * 2005-06-13 2010-08-24 Edwards Lifesciences Corporation Heart valve delivery system
US20070027533A1 (en) * 2005-07-28 2007-02-01 Medtronic Vascular, Inc. Cardiac valve annulus restraining device
US20070038295A1 (en) * 2005-08-12 2007-02-15 Cook Incorporated Artificial valve prosthesis having a ring frame
US20070043431A1 (en) * 2005-08-19 2007-02-22 Cook Incorporated Prosthetic valve
US20080188928A1 (en) 2005-09-16 2008-08-07 Amr Salahieh Medical device delivery sheath
US7682304B2 (en) 2005-09-21 2010-03-23 Medtronic, Inc. Composite heart valve apparatus manufactured using techniques involving laser machining of tissue
US20070078510A1 (en) 2005-09-26 2007-04-05 Ryan Timothy R Prosthetic cardiac and venous valves
US8167932B2 (en) 2005-10-18 2012-05-01 Edwards Lifesciences Corporation Heart valve delivery system with valve catheter
DE102005051849B4 (en) 2005-10-28 2010-01-21 JenaValve Technology Inc., Wilmington Device for implantation and attachment of heart valve prostheses
US20070100449A1 (en) 2005-10-31 2007-05-03 O'neil Michael Injectable soft tissue fixation technique
US20070100439A1 (en) 2005-10-31 2007-05-03 Medtronic Vascular, Inc. Chordae tendinae restraining ring
WO2007054014A1 (en) * 2005-11-09 2007-05-18 Ning Wen Delivery device for delivering a self-expanding stent
US20070213813A1 (en) 2005-12-22 2007-09-13 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
ES2494618T3 (en) * 2005-12-22 2014-09-15 Symetis Sa Heart valve prosthesis
US9078781B2 (en) 2006-01-11 2015-07-14 Medtronic, Inc. Sterile cover for compressible stents used in percutaneous device delivery systems
US20070203391A1 (en) 2006-02-24 2007-08-30 Medtronic Vascular, Inc. System for Treating Mitral Valve Regurgitation
US20070225681A1 (en) 2006-03-21 2007-09-27 Medtronic Vascular Catheter Having a Selectively Formable Distal Section
US20070238979A1 (en) 2006-03-23 2007-10-11 Medtronic Vascular, Inc. Reference Devices for Placement in Heart Structures for Visualization During Heart Valve Procedures
US8075615B2 (en) 2006-03-28 2011-12-13 Medtronic, Inc. Prosthetic cardiac valve formed from pericardium material and methods of making same
US20070233238A1 (en) 2006-03-31 2007-10-04 Medtronic Vascular, Inc. Devices for Imaging and Navigation During Minimally Invasive Non-Bypass Cardiac Procedures
US20070232898A1 (en) 2006-03-31 2007-10-04 Medtronic Vascular, Inc. Telescoping Catheter With Electromagnetic Coils for Imaging and Navigation During Cardiac Procedures
US7625403B2 (en) 2006-04-04 2009-12-01 Medtronic Vascular, Inc. Valved conduit designed for subsequent catheter delivered valve therapy
US7524331B2 (en) 2006-04-06 2009-04-28 Medtronic Vascular, Inc. Catheter delivered valve having a barrier to provide an enhanced seal
US7740655B2 (en) 2006-04-06 2010-06-22 Medtronic Vascular, Inc. Reinforced surgical conduit for implantation of a stented valve therein
US7591848B2 (en) 2006-04-06 2009-09-22 Medtronic Vascular, Inc. Riveted stent valve for percutaneous use
US20070239254A1 (en) 2006-04-07 2007-10-11 Chris Chia System for percutaneous delivery and removal of a prosthetic valve
US20070239269A1 (en) 2006-04-07 2007-10-11 Medtronic Vascular, Inc. Stented Valve Having Dull Struts
US20070244555A1 (en) 2006-04-12 2007-10-18 Medtronic Vascular, Inc. Annuloplasty Device Having a Helical Anchor and Methods for its Use
US7699892B2 (en) 2006-04-12 2010-04-20 Medtronic Vascular, Inc. Minimally invasive procedure for implanting an annuloplasty device
US8454683B2 (en) 2006-04-12 2013-06-04 Medtronic Vascular, Inc. Annuloplasty device having a helical anchor and methods for its use
US20070244544A1 (en) 2006-04-14 2007-10-18 Medtronic Vascular, Inc. Seal for Enhanced Stented Valve Fixation
US20070244545A1 (en) 2006-04-14 2007-10-18 Medtronic Vascular, Inc. Prosthetic Conduit With Radiopaque Symmetry Indicators
US20070244546A1 (en) 2006-04-18 2007-10-18 Medtronic Vascular, Inc. Stent Foundation for Placement of a Stented Valve
US20070288000A1 (en) 2006-04-19 2007-12-13 Medtronic Vascular, Inc. Method for Aiding Valve Annuloplasty
US7442207B2 (en) 2006-04-21 2008-10-28 Medtronic Vascular, Inc. Device, system, and method for treating cardiac valve regurgitation
EP2023859B1 (en) 2006-04-28 2012-12-26 Medtronic, Inc. Apparatus for cardiac valve replacement
JP2009536074A (en) 2006-05-05 2009-10-08 チルドレンズ・メディカル・センター・コーポレイション Transcatheter heart valve
US20080004696A1 (en) * 2006-06-29 2008-01-03 Valvexchange Inc. Cardiovascular valve assembly with resizable docking station
CN100581454C (en) * 2006-07-14 2010-01-20 Ge医疗系统环球技术有限公司 Magnetic field generator and MRI device
WO2008031103A2 (en) 2006-09-08 2008-03-13 Edwards Lifesciences Corporation Integrated heart valve delivery system
JP5106537B2 (en) 2006-09-28 2012-12-26 ハート リーフレット テクノロジーズ, インコーポレイテッド Delivery tool for transdermal delivery of prostheses
FR2906454B1 (en) 2006-09-28 2009-04-10 Perouse Soc Par Actions Simpli IMPLANT INTENDED TO BE PLACED IN A BLOOD CIRCULATION CONDUIT.
WO2008047354A2 (en) 2006-10-16 2008-04-24 Ventor Technologies Ltd. Transapical delivery system with ventriculo-arterial overflow bypass
US8747459B2 (en) 2006-12-06 2014-06-10 Medtronic Corevalve Llc System and method for transapical delivery of an annulus anchored self-expanding valve
US8070799B2 (en) 2006-12-19 2011-12-06 Sorin Biomedica Cardio S.R.L. Instrument and method for in situ deployment of cardiac valve prostheses
US8057539B2 (en) 2006-12-19 2011-11-15 Sorin Biomedica Cardio S.R.L. System for in situ positioning of cardiac valve prostheses without occluding blood flow
US8236045B2 (en) 2006-12-22 2012-08-07 Edwards Lifesciences Corporation Implantable prosthetic valve assembly and method of making the same
US9510943B2 (en) 2007-01-19 2016-12-06 Medtronic, Inc. Stented heart valve devices and methods for atrioventricular valve replacement
WO2008092101A2 (en) * 2007-01-26 2008-07-31 3F Therapeutics, Inc. Methods and systems for reducing paravalvular leakage in heart valves
CA2677633C (en) 2007-02-15 2015-09-08 Medtronic, Inc. Multi-layered stents and methods of implanting
EP2129333B1 (en) 2007-02-16 2019-04-03 Medtronic, Inc Replacement prosthetic heart valves
FR2913879B1 (en) 2007-03-21 2009-06-12 Perouse Soc Par Actions Simpli DEVICE FOR LAGGING A RADIALLY EXPANSIBLE IMPLANT, NECESSARY FOR TREATMENT AND METHOD OF RELAUNCHING
US20080255651A1 (en) 2007-04-12 2008-10-16 Medtronic Vascular, Inc. Telescoping Stability Sheath and Method of Use
US9138315B2 (en) 2007-04-13 2015-09-22 Jenavalve Technology Gmbh Medical device for treating a heart valve insufficiency or stenosis
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
EP3150171A1 (en) 2007-05-15 2017-04-05 JenaValve Technology, Inc. Handle for manipulating a catheter tip, catheter system and medical insertion system for inserting a self-expandalbe heart valve stent
AU2008260444B2 (en) 2007-06-04 2014-09-11 St. Jude Medical, Inc. Prosthetic heart valves
AU2008269018B2 (en) 2007-06-26 2014-07-31 St. Jude Medical, Inc. Apparatus and methods for implanting collapsible/expandable prosthetic heart valves
US8747458B2 (en) * 2007-08-20 2014-06-10 Medtronic Ventor Technologies Ltd. Stent loading tool and method for use thereof
EP2484311B1 (en) 2007-08-24 2015-05-06 St. Jude Medical, Inc. Prosthetic aortic heart valve
US8114154B2 (en) 2007-09-07 2012-02-14 Sorin Biomedica Cardio S.R.L. Fluid-filled delivery system for in situ deployment of cardiac valve prostheses
US8808367B2 (en) 2007-09-07 2014-08-19 Sorin Group Italia S.R.L. Prosthetic valve delivery system including retrograde/antegrade approach
ES2571740T3 (en) 2007-09-26 2016-05-26 St Jude Medical Collapsible prosthetic heart valves
WO2009045334A1 (en) * 2007-09-28 2009-04-09 St. Jude Medical, Inc. Collapsible/expandable prosthetic heart valves with native calcified leaflet retention features
US9532868B2 (en) 2007-09-28 2017-01-03 St. Jude Medical, Inc. Collapsible-expandable prosthetic heart valves with structures for clamping native tissue
US20090138079A1 (en) 2007-10-10 2009-05-28 Vector Technologies Ltd. Prosthetic heart valve for transfemoral delivery
US10856970B2 (en) * 2007-10-10 2020-12-08 Medtronic Ventor Technologies Ltd. Prosthetic heart valve for transfemoral delivery
US9848981B2 (en) 2007-10-12 2017-12-26 Mayo Foundation For Medical Education And Research Expandable valve prosthesis with sealing mechanism
WO2009053497A1 (en) * 2007-10-25 2009-04-30 Symetis Sa Stents, valved-stents and methods and systems for delivery thereof
WO2009061389A2 (en) 2007-11-05 2009-05-14 St. Jude Medical, Inc. Collapsible/expandable prosthetic heart valves with non-expanding stent posts and retrieval features
SI3646822T1 (en) * 2007-12-14 2021-10-29 Edwards Lifesciences Corp Leaflet attachment frame for a prosthetic valve
AU2009205739B2 (en) 2008-01-16 2014-09-25 St. Jude Medical, Inc. Delivery and retrieval systems for collapsible/expandable prosthetic heart valves
US9149358B2 (en) 2008-01-24 2015-10-06 Medtronic, Inc. Delivery systems for prosthetic heart valves
JP5687070B2 (en) * 2008-01-24 2015-03-18 メドトロニック,インコーポレイテッド Stent for prosthetic heart valve
US8157853B2 (en) 2008-01-24 2012-04-17 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
EP2254512B1 (en) 2008-01-24 2016-01-06 Medtronic, Inc. Markers for prosthetic heart valves
US9168130B2 (en) 2008-02-26 2015-10-27 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
US8317858B2 (en) 2008-02-26 2012-11-27 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US9011525B2 (en) 2008-02-29 2015-04-21 The Florida International University Board Of Trustees Catheter deliverable artificial multi-leaflet heart valve prosthesis and intravascular delivery system for a catheter deliverable heart valve prosthesis
US8313525B2 (en) 2008-03-18 2012-11-20 Medtronic Ventor Technologies, Ltd. Valve suturing and implantation procedures
US8696689B2 (en) 2008-03-18 2014-04-15 Medtronic Ventor Technologies Ltd. Medical suturing device and method for use thereof
JP5685183B2 (en) * 2008-04-23 2015-03-18 メドトロニック,インコーポレイテッド Heart valve device with stent
ATE554731T1 (en) * 2008-05-16 2012-05-15 Sorin Biomedica Cardio Srl ATRAAUMATIC PROSTHETIC HEART VALVE PROSTHESIS
DK3476368T3 (en) * 2008-06-06 2020-03-02 Edwards Lifesciences Corp Low profile transcatheter heart valve
ES2570592T3 (en) * 2008-07-15 2016-05-19 St Jude Medical Collapsible and re-expandable prosthetic heart valve sleeve designs and complementary technological applications
US8652202B2 (en) * 2008-08-22 2014-02-18 Edwards Lifesciences Corporation Prosthetic heart valve and delivery apparatus
US8137398B2 (en) * 2008-10-13 2012-03-20 Medtronic Ventor Technologies Ltd Prosthetic valve having tapered tip when compressed for delivery
US8986361B2 (en) 2008-10-17 2015-03-24 Medtronic Corevalve, Inc. Delivery system for deployment of medical devices
US8591573B2 (en) * 2008-12-08 2013-11-26 Hector Daniel Barone Prosthetic valve for intraluminal implantation
US8308798B2 (en) * 2008-12-19 2012-11-13 Edwards Lifesciences Corporation Quick-connect prosthetic heart valve and methods
US8834563B2 (en) 2008-12-23 2014-09-16 Sorin Group Italia S.R.L. Expandable prosthetic valve having anchoring appendages
WO2010098857A1 (en) * 2009-02-27 2010-09-02 St. Jude Medical, Inc. Stent features for collapsible prosthetic heart valves
US8021420B2 (en) 2009-03-12 2011-09-20 Medtronic Vascular, Inc. Prosthetic valve delivery system

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080281411A1 (en) * 2004-03-26 2008-11-13 Eric Berreklouw Assembly Comprising A Ring For Attachment In A Passage Surrounded By Body Tissue As Well As An Applicator For Fitting The Ring In The Passage
US20070270944A1 (en) * 2004-04-23 2007-11-22 3F Therapeutics, Inc. Implantable Valve Prosthesis
US20090005863A1 (en) * 2006-02-16 2009-01-01 Goetz Wolfgang Minimally invasive heart valve replacement
US20080071362A1 (en) * 2006-09-19 2008-03-20 Yosi Tuval Valve prosthesis implantation techniques

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2437688A4 *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9375312B2 (en) 2010-07-09 2016-06-28 Highlife Sas Transcatheter atrio-ventricular valve prosthesis
US9931206B2 (en) 2010-07-09 2018-04-03 Highlife Sas Transcatheter atrio-ventricular valve prosthesis
US11259921B2 (en) 2010-07-09 2022-03-01 Highlife Sas Transcatheter atrio-ventricular valve prosthesis
US11259922B2 (en) 2010-07-09 2022-03-01 Highlife Sas Transcatheter atrio-ventricular valve prosthesis
US11311377B2 (en) 2010-07-09 2022-04-26 Highlife Sas Transcatheter atrio-ventricular valve prosthesis
US11446140B2 (en) 2010-07-09 2022-09-20 Highlife Sas Transcatheter atrio-ventricular valve prosthesis
US11883283B2 (en) 2010-07-09 2024-01-30 Highlife Sas Transcatheter atrio-ventricular valve prosthesis
DE102014102718A1 (en) * 2014-02-28 2015-09-03 Highlife Sas Transcatheter valve prosthesis
US9763779B2 (en) 2014-03-11 2017-09-19 Highlife Sas Transcatheter valve prosthesis

Also Published As

Publication number Publication date
US9579194B2 (en) 2017-02-28
ES2902446T3 (en) 2022-03-28
EP3760164A1 (en) 2021-01-06
US20100100176A1 (en) 2010-04-22
JP2012528670A (en) 2012-11-15
EP3760164B1 (en) 2021-11-17
EP4014927A1 (en) 2022-06-22
CN102481189A (en) 2012-05-30
PT3760164T (en) 2021-12-31
EP2437688A1 (en) 2012-04-11
EP2437688A4 (en) 2018-01-10
EP2437688B1 (en) 2020-05-06
CN102481189B (en) 2014-12-10

Similar Documents

Publication Publication Date Title
EP3760164B1 (en) Heart valve with anchoring structure having concave landing zone
EP2991585B1 (en) Medical devices for implanting in a valve
US11571299B2 (en) Methods for manufacturing resilient prosthetic surgical heart valves
US20220110743A1 (en) Collapsible-expandable heart valves
US20100168844A1 (en) Methods and systems for reducing paravalvular leakage in heart valves
EP2991584B1 (en) Prosthetic valves
US9872765B2 (en) Mitral valve assembly
US20220211492A1 (en) Modified prosthetic heart valve stent
WO2023041705A1 (en) Prosthetic caval valve

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080025834.8

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10783686

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2012513922

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2010783686

Country of ref document: EP